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 The mammalian gut contains an incredibly diverse and abundant bacterial community 
that makes essential contributions to host metabolism and immune system priming. The close 
proximity of the intestinal epithelium with the gut microbiota poses serious challenges to the 
host, who in turn has developed a complex set of physical and immunological mechanisms to 
effectively manage this host-microbe relationship. A defect in any one of these mechanisms can 
result in opportunistic invasion of host tissues by otherwise commensal bacteria and this 
breakdown in homeostasis may contribute to numerous metabolic and gastrointestinal 
pathologies. Here, I investigate the role of two such mechanisms in maintaining homeostasis: 
Toll-like receptor 5 (TLR5), the innate immune receptor for bacterial flagellin, as well as IgA, 
which has previously been indicated to be aberrant in abundance and antigen specificity in the 
absence of TLR5. Using metatranscriptomics and biochemical assays, I found that TLR5-/- mice 
harbor a bacterial community that exhibits increased flagellation. I also found that TLR5 is 
required to synthesize the amount of anti-flagellin IgA observed in healthy WT mice, and 
flagellin load appears to share an inverse relationship with levels of anti-flagellin IgA. I 
performed 16S rRNA analysis of the gut microbiota in mice with or without the capacity for 
producing IgA to better understand how IgA influences the stability and resilience of the 
bacterial community. Indeed, the lack of IgA resulted in reduced temporal stability and reduced 
community evenness, as well as increased susceptibility to antibiotic-induced perturbation. To 
specifically investigate the influence of TLR5 on IgA coating of the gut microbiota, I used 
  
fluorescence activated cell sorting (FACS) combined with 16S rRNA analysis and found that the 
bacterial community of TLR5-/- mice displays an aberrant profile of IgA coating, including 
reduced coating of Proteobacteria and increased coating of Firmicutes. With a combination of 
immunohistochemistry, fluorescent in situ hybridization, and fluorescent microscopy of 
intestinal tissues, I observed that TLR5-/- mice have a defective mucosal barrier that results in 
bacterial invasion of villi in the small intestine and penetration deep into the colonic mucus layer.  
Together, these results highlight the critical role of TLR5 in maintaining gut homeostasis through 
directing the synthesis of anti-flagellin IgA and thus reducing levels of flagellation and motility 
in the bacterial community.
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1. Background 
 
The gastrointestinal tract of mammals is densely populated by a phylogenetically diverse 
suite of bacteria, commonly termed the gut microbiota. These bacteria outnumber our own cells 
by a factor of ten to one [1, 2] and harbor roughly 100 times as many genes as are found in the 
human genome [3]. The gut microbiota provides such benefits to the host as protection from 
infection by enteropathogens [4, 5], increased nutrient and energy extraction from the diet [6, 7], 
and priming and regulation of the immune system [8-10]. Conversely, the host provides its 
resident microbiota with a diversity of glycan nutrient sources and a protected anoxic 
environment [3]. The vast majority of the gut microbiota consists of strict anaerobes and this 
community is dominated by two phyla: Bacteroidetes and Firmicutes [11]. Minor populations of 
Proteobacteria, Verrucomicrobia, Actinobacteria, Fusobacteria, Cyanobacteria, as well as 
methanogenic archaea are also common residents of the mammalian gut [11, 12]. As a whole, the 
gut microbiota can be considered as an additional “organ” that provides a multitude of essential 
functions to the host [3]. 
Toll-like receptor 5 (TLR5) is one of twelve known evolutionarily conserved TLRs in 
mammals [13]. TLRs are a critical part of the innate immune system that function as membrane-
bound antigen-recognition receptors by recognizing conserved structures originating from 
bacteria, viruses, and fungi and collectively termed microbe-associated molecular patterns 
(MAMPs) [14]. TLR5 specifically recognizes bacterial flagellin, the protein monomer that 
comprises the bulk of the flagellar filament responsible for motility [15]. TLR5 is predominantly 
expressed by epithelial cells, monocytes, and dendritic cells [16-18], where upon binding to 
flagellin TLR5 induces the signaling adaptor MyD88 and activates a proinflammatory response 
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via the transcription factor, NF-κB [15]. This signaling cascade induces the inflammatory 
cytokines TNF-α and IL-6 [15], which in turn stimulate various immunological responses such 
as acute phase response, recruitment of neutrophils, and increased phagocytosis by macrophages 
[19]. The recruitment of neutrophils to mucosal surfaces is thought to serve as a particularly 
important mechanism protecting against the spread of infiltrating bacteria, but may also drive the 
intestinal inflammation observed in models of immune dysregulation [20]. 
Deletion of TLR5 in mice has resulted in such diverse pathologies as intestinal 
inflammation [20], metabolic syndrome [21], and impaired CD4 T cell responses against 
flagellated pathogens [22]. The determinants that steer this outcome are unclear, but rederiving 
TLR5-/- mice in order to change their gut microbiota to be more similar to mice housed at 
Jackson Laboratory (the world’s largest supplier of research mice) resulted in attenuation of 
colitis and an increased prevalence of metabolic syndrome [21]. Placing TLR5-/- mice on broad-
spectrum antibiotic therapy alleviates many of the symptoms of metabolic syndrome [21]. 
Likewise, transfer of the gut microbiota of TLR5-/- mice to germ-free WT recipient mice 
induces symptoms of metabolic syndrome, including increased weight gain [21]. TLR5-/- mice 
display an inability to maintain a stable community of gut bacteria and elevated levels of 
Proteobacteria [23], suggesting that the commensal microbiota of these mice may also be less 
resistant to environmental perturbation. These findings suggest that the composition of the gut 
bacterial community is a major determinant in the physiological consequences of loss of TLR5.  
Antibodies, also known as immunoglobulins, are large proteins produced by the B cells 
of all vertebrates and are developed to recognize unique structures, or antigens. There are five 
antibody isotypes produced in mammals, with IgA being the most abundant isotype by far [24, 
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25]. The bulk of IgA is secreted across mucosal surfaces in dimeric form [26], where it aids in 
barrier defense through a multitude of mechanisms. Over 95% of IgA that is secreted across 
mucosal surfaces is produced locally, either in Peyer’s patches, isolated lymphoid follicles, or 
nonorganized lamina propria [25, 27]. As a result, anywhere between 24%-74% of bacteria in the 
gut appear to be coated with IgA [28, 29], which serves to limit bacterial adherence to the host 
epithelium and penetration of the mucosal layer. IgA is able to limit undue immune responses 
through mechanisms collectively termed “immune exclusion”, which includes agglutination, 
entrapment in mucus, and peristaltic clearance of microbial antigens [30], thus preventing these 
antigens from interacting with proinflammatory receptors [31]. IgA is even capable of 
transcytosing bacterial antigens back into the lumen after they have invaded host tissues [32]. 
IgA is also thought to aid in temporal stability of the bacterial community through the 
establishment of biofilms in the gut [33, 34]. Together, these observations support the idea that 
IgA promotes gut homeostasis by defending against pathogens as well as promoting a stable gut 
microbiota without eliciting damaging proinflammatory responses [35]. 
There is accumulating evidence to suggest that TLR5 and IgA cooperate to maintain a 
homeostatic relationship between the gut microbiota and host. Germ-free mice express incredibly 
low levels of TLR5, which is upregulated upon colonization of the gut by commensal bacteria 
[36]. A prominent subset of dendritic cells (DCs), termed CD11c
hi
CD11b
hi
, reside in the lamina 
propria and express high levels of TLR5 [37]. Upon exposure to flagellin, these DCs promote the 
differentiation of B cells into flagellin-specific IgA-producing plasma cells [37]. Indeed, TLR5-/- 
mice display defects in flagellin-specific adaptive immunity [38] and IgA-deficient mice display 
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a deleterious overactive innate immune response [39, 40], suggesting that a loss of either 
component negatively impacts the performance of the other. 
It is not well understood how IgA functions once it is secreted into an external 
environment such as the intestinal lumen, despite the fact that IgA deficiency is the most 
common primary immunodeficiency in humans [41]. What is more, 5% of the human population 
carries an allele for a dominant nonfunctional TLR5 polymorphism [42], though the health 
effects of this trait are not well documented. New information on this subject is critical if 
effective therapeutic tools are to be developed. In this thesis, I investigate how anti-flagellin IgA 
and TLR5 cooperate to maintain barrier integrity at the interface between host intestinal tissues 
and the lumen. I hypothesize that TLR5 deficiency results in reduced production of anti-flagellin 
IgA, causing an increase in bacterial flagellation and inflammation of the gut. To address this 
hypothesis, I use a combination of biochemical assays, bacterial culturing, microscopy, and next-
generation sequencing to assess how gut bacterial communities respond to host TLR5 deficiency 
and the consequences of this response on host health.  
This dissertation is divided into three chapters that each focus on a particular facet of the 
interactions between the gut microbiota and its host, with an emphasis on the TLR5-/- mouse 
model. In chapter one, I discuss my findings that TLR5 is required in order to produce sufficient 
anti-flagellin IgA to inhibit bacterial motility. I expand on my research of IgA in chapter two to 
better understand which bacteria IgA targets and the role of IgA in maintaining a gut microbiota 
that displays temporal evenness and stability. Finally, in chapter three I bolster my hypothesis 
that TLR5 deficiency results in decreased mucosal integrity and increased flagellation with the 
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use of in situ microscopy of the epithelium-lumen interface and show that a diverse phylogeny of 
commensal bacteria display reduced flagellation in the presence of anti-flagellin antibodies. 
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CHAPTER 1 
 
IGA QUENCHES FLAGELLA-BASED BACTERIAL MOTILITY IN THE GUT IN A TLR5-
DEPENDENT MANNER 
 
2.1 Summary  
The mammalian gut uses a combination of physiology and immunity to inhibit its 
trillions of resident bacterial cells from eliciting harmful inflammatory responses. 
Immunoglobulin A (IgA) forms part of host barrier defense by binding bacteria to mucus, but 
questions remain about how IgA interacts with bacterial populations. Here, I report that IgA 
specific to bacterial flagellin directly suppresses motility across the microbiome and I confirm 
this finding in vitro. Host expression of Toll-like receptor 5 (TLR5) is required to synthesize 
sufficient anti-flagellin IgA, and flagellin load is inversely proportional to levels of anti-flagellin 
IgA in the mouse intestine. These results expand the role of IgA in barrier protection to include 
the quenching of gut microbial motility, and present a novel target for reducing the risk of 
metabolic inflammation. 
 
2.2 Introduction 
The spatial segregation of the microbiota away from epithelial surfaces is a critical 
element of gut homeostasis, as microbial penetration through the mucosal barrier causes 
inflammatory responses that can lead to colitis or metabolic inflammation [1, 2]. One important 
mechanism for maintaining barrier protection is immunoglobulin A (IgA), which both binds cells 
to mucus and induces their agglutination [3]. A healthy human adult secretes between 3-6 grams 
of IgA into the lumen daily, an amount that far exceeds the combined total of all other 
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antibodies’ production in the body [4, 5]. Consequently up to three quarters of the 10-100 trillion 
microbes residing in the gut are coated with IgA [6, 7]. Recent work has shown that each host 
has an individual IgA repertoire [8] that is thought to mirror the individuality of their gut 
microbiome [9]. However, bacterial penetration into mucus and the resulting inflammation have 
been reported in animal models with deficiencies in the innate immune system [10], even when 
IgA levels in the gut are high [11]. Thus, IgA alone cannot inhibit the microbiota from 
penetrating the mucus, raising questions about how the innate immune system interacts with the 
adaptive immune system to maintain the spatial segregation of host and microbiota.   
Directed motility in the gut may provide distinct advantages to host-adapted bacteria, 
such as increased penetration into the mucosa, but little is known about the fitness advantages of 
motility other than specific models of pathogenic infection. The ability to produce flagella is a 
trait widely shared by commensal gut bacteria representing a wide taxonomic diversity (e.g., 
many members of the phyla Firmicutes, Actinobacteria, and Proteobacteria are motile). Their 
capacity for motility is also evident from the motility genes recovered in healthy gut 
metagenomes [12, 13]. However, flagellin is a potent immune stimulator that could cause the 
host to mount an unwanted proinflammatory response against flagellated commensal bacteria. 
Furthermore, the assembly and use of flagella is metabolically expensive [14] and the intestinal 
environment nutrient-dense, such that flagellation in the gut is widely assumed unnecessary 
outside of select pathogens. In fact, flagellin levels are low in healthy human stool [15], 
suggesting low levels of motility overall. These observations suggest that a large fraction of the 
microbiota have the capacity for motility but do not express motility genes in the gut.  
High levels of flagellin, along with barrier breakdown, have been associated with 
inflammation in Crohn’s disease and colitis [16, 17]. Research is unable to link a specific 
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pathogen to these diseases and it has been suggested that a breakdown of host-microbiome 
homeostasis is responsible for their onset. It is unclear how a symbiotic microbiome develops 
into a bacterial community with pathogenic characteristics, but the increased rate of 
immunodeficiency among individuals with Crohn’s disease, inflammatory bowel disease, and 
colitis suggest that loss of homeostasis is likely to stem from improper immune responses.  
A few species of bacteria have been shown to downregulate the expression of specific 
antigens to evade antibody coating [3, 18]. Also, some reports have shown that IgA can alter 
bacterial gene expression [18-20], but whether IgA impacts the expression of motility genes is 
unknown. Unlike constitutively expressed antigens such as lipopolysaccharide, the expression of 
flagella is optional [21, 22], and motility is selected against in the healthy gut [23]. These results 
indicate that a failure of the host’s adaptive immune system to restrain the inherent capacity for 
flagellation in the gut microbiome may be a risk factor for such diseases. We have shown that the 
microbiota of mice deficient in Toll-like receptor (TLR) 5 induce metabolic inflammation when 
transferred to wildtype (WT) germ-free recipients, and that this inflammatory microbiota is less 
temporally stable, and more enriched in Proteobacteria, compared to WT microbiota  [24]. 
However, the host-microbial interactions underlying the shift in microbiota remain unclear.  
Here, I investigate the importance of TLR5 in regulating gene expression of the gut 
microbiome and the role of IgA directed against bacterial flagella. I combine metagenomics and 
metatranscriptomics to analyze the functional capacity and active gene expression of the gut 
microbiome of TLR5-/- mice compared to WT mice. I then use enzyme-linked immunosorbent 
assays (ELISAs) and a reporter cell assay to quantify the amount of flagellin and anti-flagellin 
antibodies present in the fecal and cecal contents of these mice. To determine the potential 
influence of antibodies on the fitness of flagellated bacteria, I employ a gnotobiotic mouse model 
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and compare the ability of a flagellated E. coli to thrive in the presence or absence of host 
antibodies. Next, I investigate the potential of anti-flagellin antibodies to stimulate 
downregulation of bacterial flagellin and inhibit bacterial motility using an engineered E. coli 
flagellin reporter strain as well as motility plate assays. Lastly, I extend my scope of 
investigation to find out if the phenotypic markers of TLR5-/- mice are applicable to NLRC4-/- 
mice, which lack the ability of intracellular flagellin detection, as well as normal weight and 
obese humans. 
 
2.3 Results and Discussion 
To assess how the absence of TLR5 alters the active function of the gut microbiome, I 
profiled the community-level gene expression of the entire microbiomes of five eight-week old 
TLR5-/- mice and six WT mice of the same age using shotgun metatranscriptomic sequencing. I 
purified total RNA from cecal microbiomes and used custom probes to selectively pull down 
rRNA, thus enriching for mRNA, prior to cDNA synthesis and Illumina sequencing [25]. This 
approach resulted in between 289,970 to 2,670,042 reads per mouse (Table 1).  
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Table 1. Number of sequences generated for the metagenomic and meta-transcriptomic 
analyses. Sequences were generated the 454 Titanium and Illumina HiSeq2000 sequencing 
platforms. Values are linked to their corresponding samples on the MG-RAST server. 
Metagenome Metatranscriptome  
454 Titanium Illumina HiSeq2000 
WT1 62,079 WT1 50,265,870 WT1                1,854,639 
WT2 81,981 WT2 36,401,312 WT2                   867,799 
WT3 59,515 WT3 31,012,847 WT3                1,682,469 
WT4 74,533 WT4 53,119,526 WT4                   391,021 
    WT5                   633,254 
    WT6                1,059,826 
TLR5-/-1 55,151 TLR5-/-1 29,535,962 TLR5-/-1         1,236,464 
TLR5-/-2 73,413 TLR5-/-2 33,884,214 TLR5-/-2         2,231,408 
TLR5-/-3 64,550 TLR5-/-3 14,850,852 TLR5-/-3         2,670,042 
TLR5-/-4 27,581 TLR5-/-4 38,445,732 TLR5-/-4            289,970 
    TLR5-/-5         3,293,206 
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Sequences were filtered for quality and uploaded to the metagenomics analysis server 
MG-RAST and potential functions were assigned using the Clusters of Orthologous Groups 
(COGs) annotation source. Taken as a whole, the metatranscriptomes of TLR5-/- and WT mice 
were not significantly different. I then selected the COG categories that displayed at least a two-
fold difference between the genotypes. Now, the metatranscriptomes segregated clearly by host 
genotype (Fig. 1), based on unsupervised hierarchical clustering of samples based on the 
enrichment or depletion of COGs in the metatranscriptomes. Notably, of the six COG categories 
significantly enriched in TLR5-/- samples, three were associated with the manufacture and 
assembly of bacterial flagella.  
Taxonomic assignment of the flagellum-associated genes over-expressed in TLR5-/- 
transcriptomes compared to WT showed that these motility-related gene transcripts were 
expressed by phylogenetically diverse bacteria, including commensal bacteria such as butyrate-
producing Firmicutes (e.g., Roseburia, Eubacterium, Clostridium), Bacteroidetes (Bacteroides 
pectinophilus), and Proteobacteria (e.g., Desulfovibrio spp.) (Figure 2). In total, 18 COGs in the 
TLR5-/- metatranscriptome had significantly different abundances relative to WT. In addition to 
presenting an enrichment in flagellar motility in TLR5-/-mice, these COGs indicate a depletion 
in carbohydrate metabolism and antimicrobial peptide transport functions and are sufficient to 
reliably segregate samples by host genotype (Figure 1).  
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Figure 1. Flagella-related genes are upregulated in the TLR5-/- metatranscriptome, but not 
in the metagenome. cDNAs assigned to the 18 most significant COG categories were 
normalized and hierarchically clustered. Dendrogram (bottom) shows clustering of samples 
based on the uncentered correlation similarity metric. Correlation coefficients are represented by 
color ranging from blue (-5x depletion relative to mean values across genotypes) to yellow (5x 
enrichment). Metagenomic reads from the same 18 COG categories were processed similarly. 
Functional categories are indicated in the legend; flagella-associated gene categories are 
highlighted in red.  
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Figure 2. Metatranscriptomic reads annotated as flagellin are phylogenetically diverse. I 
used hierarchechal classification and the Subsystems database in MG-RAST to annotate 
function. I isolated reads with an annotation of flagellin and assigned taxonomy using BLASTX 
with default arguments. Taxonomic assignments are shown to the species level, with abundance 
of reads corresponding to the key at bottom. Note that Bacteroides pectinophilus is a Firmicute 
based on 16S rRNA gene sequence analysis but misclassified in the phylum Bacteroidetes in the 
MG-RAST database. 
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A difference in gene transcripts between genotypes could reflect differences in 
metagenomes (total gene content of the microbiome) rather than gene expression, so it is 
important to check the proportion of motility genes. Thus, I also characterized the gene content 
of the gut microbiomes of four eight-week old male TLR5-/- mice and age/gender matched WT 
mice using shotgun metagenomics and the Illumina HiSeq2000 sequencing platform. This 
analysis did not reveal any significant differences between TLR5-/- and WT microbiome 
functional gene content, including motility genes, suggesting that the shift in microbial diversity 
was too slight to impact the functional potential of the microbiota (Figure 1). I confirmed this 
finding and increased the sample size and average read length by repeating the analysis with new 
mice and sequencing using the 454 Titanium platform. The 454 dataset agreed with the 
functional assignments given to the Illumina reads. Thus, although the metagenomic analysis 
showed that the overall functional potential of the microbiota was similar between TLR5-/- and 
WT hosts, the metatranscriptomic analysis revealed that motile bacteria belonging to a suite of 
different phyla upregulate their motility genes when anti-flagellin IgA production is low. 
To verify that the greater transcription of flagella-associated genes in the TLR5-/- host 
resulted in elevated levels of flagella, I estimated flagellin load using a TLR5-reporter cell assay 
[26]. This assay uses HEK293 cells that are engineered to secrete alkaline phosphatase in 
response to TLR5 stimulation, which can then be measured in the culture supernatant as a proxy 
for units of flagellin stimulation. I standardized flagellin levels by using the TLR5-stimulation 
potential of flagellin purified from Salmonella typhimurium strain 14028. I observed that 
flagellin levels were significantly elevated in the cecal contents and fecal pellets of TLR5-/- mice 
(Figure 3A).  
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Figure 3. Flagellin load is consistently higher in TLR5-/- mice relative to WT mice. I 
quantified flagellin load in the cecal contents of TLR5-/-, MyD88-/-, RAG1-/- and WT mice with 
or without DSS treatment (n=5-8), aged 10-23 weeks. A) Quantification of flagellin load in 
TLR5-/- and WT mice as well as cecal contents of the same mice. B) Quantification of flagellin 
load in MyD88-/- and DSS-treated WT mice in addition to TLR5-/- and non-treated WT mice for 
reference. C) Quantification of flagellin load in the feces of TLR5-/- and WT mice from four 
different facilities. EU, Emory University; CU, Cornell University; UCD; University of 
California, Davis; UP, University of Pittsburgh. University of Pittsburgh was unable to provide a 
WT control sample. Columns represent mean concentrations of flagellin (± s.e.). D) 
Quantification of flagellin in WT and RAG1-/- mice monocolonized with segmented filamentous 
bacteria (SFB). Values are below limit of detection. Mouse type is indicated on the x-axis in A) 
and C) and in the top legend in B) and D). *p < 0.01, **p < 0.001; two-tailed t-test; n.s., 
nonsignificant. 
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Since TLR5-/- mice display elevated inflammatory markers, I needed to differentiate 
whether increased flagellin levels were a result of innate immune deficiency or simply 
inflammation. To do this, I used MyD88-/- mice, which also have impaired TLR5 signaling 
(though partial via TRIF [27]) but display no elevation of inflammatory markers. I also used 
immunocompetent WT mice that were treated with dextran sulfate sodium (DSS) to chemically 
induce inflammation. Flagellin levels were significantly elevated in MyD88-/- mice, but DSS-
treated WT mice were similar to untreated WT (Figure 3B), supporting the role of TLR5 in this 
trait. To ensure that the increased flagellin load observed in TLR5-/- mice was not simply due to 
aberrant microbiota in a single facility, I also measured flagellin load in TLR5-/- from three 
additional facilities (Figure 3C). TLR5-/- mice displayed increased flagellin load compared to 
WT, regardless of facility. Though still significantly elevated, flagellin levels in TLR5-/- mice 
housed at Cornell University and University of California, Davis are reduced compared to the 
flagellin levels of TLR5-/- mice housed at Emory University and University of Pittsburgh. This 
suggests that, though the trend is the same, there still may be variations in these facilities at the 
level of bacterial community or gene expression profiles.  
Segmented filamentous bacteria (SFB) are common members of the gut microbiome of 
rodents, where they adhere tightly to the epithelium of the small intestine [28]. I became 
interested in SFB due to their potent effect on the host immune system [29] as well as the recent 
finding that the SFB genome possesses genes for flagella [30]. They have been shown to expand 
in abundance in mice lacking IgA [31] and in mice lacking MyD88 [32]. However, I did not 
identify gene transcripts from SFBs in our metatranscriptomes, despite the fact that they have 
been detected at low abundance in mice from this facility and are likely present [33]. SFB cannot 
currently be cultured ex vivo [34], so to determine if SFB flagellin is capable of stimulating 
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TLR5, I obtained cecal contents from gnotobiotic mice that were monocolonized with SFB by 
Daniel Peterson at the University of Nebraska–Lincoln. In addition to WT mice, I also used the 
cecal contents of RAG1-/-  mice that are incapable of producing IgA and may therefore maintain 
a higher bacterial load of SFB. I tested for the ability of cecal contents to simulate TLR5 in vitro, 
and could not detect any TLR5 stimulatory capacity for the microbiota of either mouse type 
(Figure 3D). These results suggest that either SFB do not express flagellin when in the ceca of 
mice or that SFB flagellin does not stimulate TLR5. Despite the abundance of SFB observed in 
rodents, there are only two reports of SFB recovered from the human intestine [28, 35]. An 
additional possibility is that the TLR5 protein used in this assay, which is of human origin, is 
unable to recognize SFB flagellin even though murine TLR5 is capable of doing so.  
 With the exception of a subset of mechanisms [36], B cells require CD4+ T cell activation before 
they can mature into antibody-producing plasma cells [37]. TLR5-/- mice have an impaired T cell 
response to flagellin [38], suggesting that they may have insufficient plasma cells producing flagellin-
specific antibodies. Furthermore, reduced anti-flagellin IgA levels have been noted in the serum of TLR5-
deficient human hosts [39]. To determine if TLR5-/- mice are impaired in their ability to produce the 
same proportion of flagellin-specific antibodies as is found in WT mice, I assessed the levels of total and 
flagellin-specific IgA and IgG in the feces of TLR5-/- mice. I measured significantly lower levels of anti-
flagellin IgA and IgG in the feces of TLR5-/- compared to WT mice, despite higher total antibody 
concentrations (Figure 4). Anti-flagellin IgA levels were also low in MyD88-/- mice, whereas levels in 
DSS-treated mice were normal. These data suggest that loss of TLR5 signaling leads to reduced anti-
flagellin IgA production in the gut regardless of inflammation. 
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Figure 4. TLR5-/- mice have reduced anti-flagellin immunoglobulins compared to WT 
mice, despite higher total immunoglobulin levels. I quantified anti-flagellin IgA and IgG as 
well as total IgA and IgG concentrations in the cecal contents of TLR5-/-, MyD88-/-, and WT 
mice with or without DSS treatment (n=8), aged 10-23 weeks. A) Total IgA concentration. B) 
Flagellin-specific IgA. C) Total IgG concentration. D) Flagellin-specific IgG. Mouse type is 
indicated in the top legend. *P < 0.01, **P< 0.001; two-tailed t-test; ns, nonsignificant. 
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There are several examples of IgA negatively impacting the fitness of commensal gut 
bacteria [31, 40]. To test if the competitive balance of the microbiota is altered in the absence of 
anti-flagellin IgA, I collaborated with Jens Walter and Laura Junker at University of Nebraska–
Lincoln in using a simplified gnotobiotic system to reliably quantify the population of flagellated 
bacteria in RAG1-/- mice. Jens Walter and Laura Junker colonized germ-free RAG1-/- and WT 
mice with the motile E. coli MG1655 as well as the non-motile Bifidobacterium adolescentis 
FST-1 and non-motile Bacteroides thetaiotaomicron VPI-5482. The three bacterial species were 
quantified by Jens Walter and Laura Junker after one week using both plate culture methods and 
denaturing gradient gel electrophoresis (DGGE), (Figure 5A, B). Both methods showed that each 
of the three species colonized WT and RAG1-/- mice equally well. I then measured flagellin in 
the RAG1-/- mice and found them to be significantly higher than WT despite similar population 
levels of E. coli (Figure 5C). This suggests that the increased motility of E. coli did not 
significantly improve its competitiveness against the two non-motile species.  
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Figure 5. A lack of IgA is associated with increased flagellin load but does not significantly 
alter fitness of flagellated bacteria. Gnotobiotic WT and RAG1-/- mice were colonized with 
Bacteroides thetaiotaomicron (Bt), Bifidobacterium adolescentis (Ba), and E. coli (Ec) and 
sacrificed after one week to assess bacterial communities (n=10). A) Denaturing gel gradient 
electrophoresis. Equal intensity bands across samples indicate equal population sizes, within a 
given species. B) CFU counts of bacteria cultured from the ceca. C)  Flagellin load in ceca. Bars 
are means ± s.e., *p < 0.001; two-tailed t-test; ns, non-significant. 
 
  
 36 
 
To verify that antibodies impacted flagella production directly, I used a flagellin gene 
(fliC) reporter E. coli (courtesy of Anthony Hay, Cornell University). This E. coli is engineered 
to have a green fluorescent protein (GFP) gene that is regulated by a fliC promoter sequence and 
allows GFP signal to serve as a proxy for flagellin production. I measured the GFP signal of the 
E. coli in liquid medium to which I added anti-FliC antibody, anti-LPS antibody as a control, or 
glucose (a known inhibitor of flagellin expression [41, 42]). The addition of anti-LPS antibodies 
to the reporter culture had no effect on flagellin gene expression, whereas glucose and anti-FliC 
antibodies each reduced the expression of flagellin significantly within two hours of addition 
(Figure 6A). These data suggest that it is not simply antibody recognition of bacteria that causes 
a reduction in flagella, but rather the specific binding of the flagellar structure by anti-flagellin 
antibodies. Interestingly, the E. coli grew equally well with or without the addition of antibody, 
supporting the observation that motility did not offer E. coli a fitness advantage in the 
gnotobiotic mouse model. 
Though this bioreporter provides important insight to the regulation of flagellin by E. 
coli, it does not address the question of whether anti-flagellin antibodies can actually affect 
motility. I confirmed the relevance of this bioreporter to the motility of E. coli with the use of 
0.3% agar motility plates. I stab inoculated E. coli into the center of each culture plate either with 
or without the addition of anti-FliC or anti-LPS antibodies. Whereas anti-LPS antibodies had a 
partial impact on the size of the resulting motility rings, anti-FliC appeared to inhibit motility 
completely (Figure 6B). The discrepancy between anti-LPS reducing motility without inhibiting 
flagellin expression as observed with the bioreporter may be due to steric hindrance caused by 
large amounts of antibody binding to the cell surface of E. coli.   
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Figure 6. Anti-flagellin antibodies cause reduced expression of flagellin and reduced 
motility in E. coli. A) Normalized GFP signal from the engineered FliC-reporter E. coli, 
monitored for 12 hours after treatment with anti-LPS or anti-flagellin antibodies. Glucose is a 
negative control as it downregulates flagella expression. Means ± s.e. for ratios of normalized 
GFP fluorescence:OD are plotted, n=3/group. B) I assessed inhibition of motility by plating E. 
coli onto motility plates containing 0.3% agar. Liquid culture with or without the addition of 
antibody was stabbed into the center of each plate. Plates were incubated at 37° for 14 hours. 
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The prevalence of metabolic syndrome and obesity among adults in the United States is 
reported to be 23.7% and 35.7%, respectively [48]. Obesity in humans is commonly associated 
with low-grade metabolic inflammation [49]. To better understand if my findings in mice with 
metabolic syndrome are transferrable to the human condition, I measured levels of anti-flagellin 
IgA and flagellin in fecal samples obtained from 43 healthy adults (62.5±1.3 years old) with a 
range of body mass indices (BMI) from normal weight to obese. Consistent with my 
observations in mice, I found that anti-flagellin IgA levels were inversely proportional to 
flagellin in human feces (R
2
=0.39, Figure 7A). Interestingly, fecal samples from normal-weight 
subjects (18.5 ≤ BMI < 25) contained significantly higher levels of anti-flagellin IgA and lower 
flagellin compared to obese subjects (BMI ≥ 30), while overweight subjects (25 ≤ BMI < 30) had 
intermediate values (Figure 7B). Thus, I propose that excessive gut flagellin, which can result 
from an impaired adaptive immune response to flagellin, could be a risk factor for metabolic 
syndrome in humans. An alternative explanation might be that increased host adiposity 
stimulates increased flagellin production. However, reports of the ability of the gut microbiota to 
promote metabolic syndrome and insulin desensitization through stimulating host 
proinflammatory signaling [50, 51] suggest that an aberrant microbiota is more likely a cause 
than an effect of such phenotypes. 
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Figure 7. Flagellin load in feces is inversely correlated with anti-flagellin IgA in humans. A) 
Flagellin load (y-axis) correlated with anti-flagellin IgA concentration (x-axis) for 43 human 
stool samples. R
2
 represents the coefficient of determination. B) Mean concentration ± s.e. of 
flagellin load and anti-flagellin IgA concentration for human subjects segregated by their BMI of 
normal (18.5-24.9, N=17), overweight (25-29.9, N=11) or obese (>30, N=15). Flagellin 
concentration is denoted on the left and anti-flagellin IgA concentration is denoted on the right. 
*P < 0.05; one-way analysis of variance (ANOVA).  
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2.4 Conclusion 
I describe a dramatic shift in the actions of the gut microbiota due to a lack of the innate 
immune receptor TLR5. In TLR5-/- mice the gut microbiota express increased transcripts 
relating to the structure and regulation of flagella, despite the lack of any discernible shift in the 
metagenomic potential of the bacterial community in relation to WT mice. I confirmed the 
increased flagellin load in the TLR5-/- mouse gut using a cell reporter assay and suggest that this 
increase is in response to host immunodeficiency rather than inflammation. Not only are TLR5-/- 
mice deficient in their innate immune response to flagellin, but they also secrete significantly 
fewer flagellin-specific antibodies into the gut.  
These results suggest that antibody quenching of bacterial motility is a fundamental 
component of homeostasis in the mammalian gut, and that bacteria are active participants in this 
process. Several studies have shown that bacteria can evade IgA coating by halting production of 
the antigen to specific IgA [18-20]. IgA binds bacterial cells to mucus, inhibiting their 
penetration through the mucosal barrier and into host tissues and thereby staving off damaging 
inflammatory responses [1, 2, 52]. IgA also limits the association of bacteria with the epithelial 
cell surface [31] and plays a role in directing bacteria from the lumen to dendritic cells in the 
mucosal compartment [53]. My results suggest an additional, specific role of IgA: down-
regulation of motility genes (i.e., quenching motility), reducing the microbiota’s ability to 
penetrate mucus and reducing the amount of highly immunoreactive protein (i.e., flagellin) in the 
gut. This results in an active barrier of protection for the healthy host to maintain gut 
homeostasis and limit inflammation. 
Flagella are critical in the pathogenesis of certain disease-causing bacteria [54, 55], but 
little is known about the role of flagella in commensal bacteria of mammalian hosts. Flagella are 
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metabolically expensive [14] and elicit powerful immune responses from the host [56], 
suggesting that commensal bacteria would only remain flagellated if this conferred a significant 
fitness advantage inside the mammalian gut. In fact, flagellated commensal E. coli are at such a 
disadvantage in the WT mouse gut that aflagellate mutants reach 90% prevalence within one 
week of colonization [23, 57]. Even so, it is possible that a flagellated commensal bacterium 
would have a selective advantage in an immunodeficient host. However, I did not observe that 
flagellated E. coli were more competitive in the RAG1-/- mouse, which lacks antibodies. Since 
this E. coli still produced significantly more flagellin in the absence of antibodies, it is possible 
that the conferred fitness advantage was too subtle to detect with DGGE or plated colony counts. 
Many of the healthy human gut’s 100 trillion bacteria are capable of motility. Commensal 
members of the phyla Firmicutes and Proteobacteria possess motility genes that are readily 
detectable in healthy gut metagenomes [12, 13]. However, flagellin is only a small component of 
a healthy gut proteome [15]. The bacterial response to anti-flagellin antibodies (i.e., reducing the 
expression of genes related to the structure, assembly, and regulation of flagella) appears to be 
evolutionarily conserved across phyla. I suggest that normal gut homeostasis requires a balance 
between motility allowing chemotaxis and immune pressure to quench production of the highly 
inflammatory flagellin protein. The inability to control commensal motility in the gut may be a 
factor predisposing a host to inflammation, and may represent a target for therapeutic 
intervention for the treatment and prevention of inflammation in the context of chronic intestinal 
inflammatory conditions and metabolic disease. 
2.5 Materials and methods 
Animal experiments: All mice used in this study were C57BL/6 strain. All mice used in 
metagenomics and metatranscriptomics  analyses were maintained at Emory University. Mice 
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used in flagellin and antibody quantification were either (1) obtained from the Jackson 
Laboratories and maintained at Cornell University, (2) derived as previously described [24] and 
housed at Emory University, or (3) housed at the University of Nebraska–Lincoln. All 
gnotobiotic mice were developed and maintained at University of Nebraska–Lincoln. All animal 
experiments were approved by the local IACUCs. Additional TLR5-/- ceca used to quantify 
flagellin load across facilities were obtained from University of Pittsburgh and University of 
California Davis (provided by David Hackam and Stephen McSorley, respectively). MyD88-/- 
and DSS-treated mice were maintained at Emory University. For DSS treatment, C57BL/6 WT 
mice were administered 2.5% DSS (MBL Biomedicals) in drinking water for 7 days immediately 
preceding sample collection. 
 
Metatranscriptomic analysis: For my samples, I used six age- and gender-matched eight week 
old male TLR5-/- mice and WT mice, housed at Emory University. These mice were sacrificed 
and their cecal contents were immediately placed in RNAlater solution (Qiagen) and frozen. 
Samples were express shipped to Cornell University on dry ice. To prepare the samples for 
nucleic acid extraction, I thawed and briefly centrifuged the samples and pipetted off the 
supernatant containing the RNAlater solution. I divided cecal contents in half and extracted bulk 
RNA and bulk DNA in parallel using the Powersoil RNA Isolation kit and Powersoil DNA 
isolation kit, respectively, as described by the manufacturer (MoBio Laboratories Ltd, Carlsbad, 
CA).  
I enriched the bulk RNA for nonribosomal RNA using a modification of a technique 
previously described [59]. This technique involves the construction of sample-specific probes to 
selectively deplete ribosomal RNA prior to cDNA synthesis. Briefly, I used a 2100 Bioanalyzer 
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(Agilient, Santa Clara, CA) and RNA 6000 Pico chip kit (Agilient, Santa Clara, CA) to detect the 
presence of ribosomal subunits based on size. Eukaryotic and Archaeal ribosomal subunits were 
not detected in the bulk RNA, thus no efforts were made to remove them. For each mouse, I 
generated sample-specific ribonucleotide probes targeting bacterial 16S and 23S rRNA genes by 
PCR amplifying these gene sequences from the bulk DNA using the universal primers 27F and 
1492R for 16S and 189F and 2490R for 23S. I separately converted these 16S and 23S rRNA 
gene sequence amplicons to biotinylated antisense rRNA probes, which hybridized to 
complementary rRNA molecules in the total RNA sample. I confirmed subtraction efficiency by 
observing the absence of 16S and 23S rRNA peaks from the total RNA profiles using a 2100 
Bioanalyzer and the RNA 6000 Pico chip kit. Next, I converted rRNA-subtracted samples to 
double-stranded cDNA, amplified via in vitro transcription, and converted back to double-
stranded cDNA,. This cDNA was used directly for pyrosequencing at the Core Laboratories 
Center at Cornell University using the Illumina HiSeq 2000 platform. 
I used the LSU and SSU reference databases from SILVA (http://www.arb-silva.de/) to 
separate Illumina reads with >70% similarity to a database rRNA sequence. Using this approach, 
I identified 40.2% of the reads as ribosomal and removed them from downstream analysis. I 
uploaded the non-ribosomal reads to MG-RAST (33) with the default quality filtering. COG 
relative abundance data for protein-coding reads were summarized using MG-RAST (e-value < 
10
-5
; ID > 50%; length > 20 aa). I uploaded functional assignments to Cluster 3.0 and centered 
and normalized counts before performing hierarchical clustering using the uncentered correlation 
similarity metric. This output was converted to a heatmap using Java Treeview 1.1.4r3 (34). To 
assign taxonomy to sequences annotated as flagellin, I used hierarchechal classification and the 
Subsystems database in MG-RAST to annotate function using default cutoff parameters. I 
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isolated reads with an annotation of flagellin and assigned taxonomy using BLASTX (35) with 
default arguments. I visualized the BLAST results using MEGAN version 3.2.1 (36). 
 
Metagenomic analysis: Four age/gender-matched 8-week old TLR5-/- mice and WT mice were 
sacrificed and their ceca were immediately removed and snap frozen. I extracted bulk DNA as 
described above. I quantified the purified DNA using Quant-iT PicoGreen dsDNA assay 
(Invitrogen, Carlsbad, CA). The products were assigned unique Multiplex Identifiers (MIDs) and 
sequenced at the Core Laboratories Center at Cornell University on the Roche 454 FLX 
platform. An additional 4 mice of each genotype were similarly processed and sequencing was 
performed at the DNA Sequencing Lab (Columbia University Medical center) using the Illumina 
HiSeq 2000 platform. I quality filtered sequence reads (trimmed ends at quality scores with code 
"B" or any ambiguous base) and uploaded to MG-RAST (33) with the default quality filtering 
and without identical read dereplication. Taxonomy assignments (LCA) and COG relative 
abundance data for protein-coding reads were summarized using MG-RAST (e-value < 10
-5
; ID 
> 50%; length > 20 aa).   
 
Measurement of antibodies via ELISA: I measured total IgA, total IgG, flagellin-specific IgA, 
and flagellin-specific IgG in fecal and cecal samples by ELISA as previously described [60, 61]. 
Briefly, ELISA plates (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) were coated overnight 
at 4°C with 1 µg/ml of purified flagellin from Salmonella Typhimurium strain 14028 (Enzo Life 
Sciences, Inc., Farmingdale, NY) or left uncoated for total antibody quantification. I prepared 
fecal and cecal samples by diluting to 0.25 mg/ml in PBS and homogenizing for 10 seconds 
using a Mini-Beadbeater-24 (BioSpec, Bartlesville, OK) without the addition of beads. The 
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detection antibodies that I used were goat anti-mouse IgA or anti-mouse IgG-HRP (Sigma, St. 
Louis, MO, USA) and I used TMB as a colorimetric reagent (Sigma, St. Louis, MO, USA). I 
stopped reactions with 0.18M H2SO4 before reading at 450 nm with a Synergy H1 plate reader 
(Biotek, Winooski, VT). Results presented here are representative for three total runs of the 
experiment, each of which included one technical replicate per sample. 
 
Flagellin quantification: I quantified flagellin using HEK-Blue-hTLR5 cells according to the 
manufacturer (Invivogen, San Diego, CA). Briefly, I suspended between 10-100 mg of either 
cecal or fecal material in PBS at a concentration of 25 mg/ml and homogenized for 10 seconds 
using a Mini-Beadbeater-24 without the addition of beads (BioSpec, Bartlesville, OK). I then 
centrifuged the samples at 8,000g for 2 min, performed two 10-fold serial dilutions on the 
resulting supernatants, and applied 20 µl of each dilution to 180 µl of mammalian cells. After 20-
24 h of incubation, I applied cell culture supernatant to HEK-Blue Detection medium 
(Invivogen, San Diego, CA) and measured alkaline phosphatase activity at 620 nm every 30 min 
for 3 h on a Synergy H1 multiple detection microplate reader (Biotek Instruments Inc., 
Winooski, VT). Presented results are representative for one repeat of the experiment and both 
experiments included one technical replicate per sample. I used purified Salmonella typhimurium 
strain 14028 flagellin (Enzo Life Sciences, Inc., Farmingdale, NY) to produce a standard curve. 
As a control for TLR5 specificity, I included one additional replicate per sample, per plate, to 
which I added anti-hTLR5 neutralizing antibody (5 µg/ml) (Invivogen, San Diego, CA). Alkaline 
phosphatase measurements in these wells represented nonspecific activity and were subtracted 
from the final quantification.  
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Monitoring flagellin expression of E. coli bioreporter: I grew E. coli strain PHL628 in 
minimal salts medium (MSM) containing 0.2% glucose (as an inhibitor of flagellin expression) 
and ampicillin (15 mg/L) at 37°C to an OD600 of 0.8+0.2. I then diluted the culture 1:100 in 
MSM containing either 0.2% glucose or 0.2% casamino acids. Casamino acids aid E. coli to 
grow in the absence of glucose without affecting flagellin production. I divided cultures into 100 
µl aliquots in 96 well clear flat-bottom plates (Costar, Corning, NY) and incubated at 37°C with 
periodic shaking on a Synergy H1, multiple detection microplate reader (Biotek Instruments Inc., 
Winooski, VT). OD600 and fluorescence of the fliC promoter fusion (Abs/Em: 488/509 nm) 
were measured every 30 minutes over the course of 15 hours. I added antibodies after 2 hours of 
growth at a concentration of (5 µg/ml) [64]. The fluorescence values were normalized to growth. 
Results presented are representative for three repeats of the experiment, each of which included 
one technical replicate per sample.  
 
Motility plates: I confirmed downregulation of flagella using Luria-Bertani (LB) broth motility 
plates containing 0.3% agar. I grew E. coli  strain BW25113 in liquid LB at 37°C to an OD600 
of 0.8+0.2. I then stab inoculated 5 µl of liquid culture with or without the addition of antibody 
(0.1 mg/ml) into the center of each plate. Plates were incubated at 37°C for 14 hours and imaged 
immediately using a BioDoc-It Imaging System (UVP, Upland, CA). Results are representative 
for two repeats of the experiment. 
 
Statistics: I performed statistical analysis and linear regression analysis in Microsoft Excel 2011, 
StatPlus 2009, R version 2.11.1, and IBM SPSS Statistics. Statistical tests were 1-way ANOVA, 
unpaired student ‘t’-test, or generalized mixed linear model, as indicated. Significance level of 
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p<0.05 unless otherwise indicated. 
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CHAPTER 2 
LOSS OF TLR5 ALTERS MICROBIOTA-ANTIBODY ASSOCIATIONS IN THE MOUSE GUT, 
WHICH NORMALLY AID IN MAINTAINING A STABLE AND RESILIENT GUT MICROBIOME 
 
3.1 Summary 
 Temporal stability of the gut microbiota, as well as the microbiota’s resilience in the face 
of environmental perturbation, are increasingly acknowledged as hallmarks of a healthy gut 
ecosystem. This homeostasis requires constant inputs from the host through a healthy lifestyle 
and immunological response - particularly, the effective production and secretion of IgA into the 
intestinal lumen. Defective IgA responses to commensal bacteria are implicated in multiple 
gastrointestinal disorders including inflammatory bowel disease and colitis. To better understand 
the role of IgA in maintaining a stable bacterial community, I performed 16S rRNA sequencing 
of gut bacteria in mice with and without IgA-producing capabilities over a period of two months. 
I found that IgA is critical in maintaining community evenness and resiliency to environmental 
perturbation. TLR5 is critical to the proper functioning of IgA, so I combined fluorescence 
activated cell sorting (FACS) with 16S rRNA sequencing to investigate which members of the 
gut bacterial community were coated with IgA in TLR5-/- mice and how this differed from 
immunocompetent WT mice. I found that Proteobacteria, which are in greater abundance in the 
gut of TLR5-/- mice as well as other immunodeficient models, were significantly less coated 
with IgA in TLR5-/- mice compared to WT mice, while the opposite pattern was true for 
Firmicutes. These results increase our understanding of the role of IgA in maintaining gut 
homeostasis, suggesting that metabolic syndrome and the dysbiosis observed in TLR5-/- mice 
result from defects in both the innate and adaptive immune systems. 
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3.2 Introduction 
 Previous studies have made the observation that gastrointestinal disorders are associated 
with temporally unstable bacterial communities [1, 2], while healthy individuals maintain a 
stable microbiome [3, 4]. Of course, stability in this system is not absolute, and even healthy 
individuals experience some degree of fluctuation in the composition of their microbiota due to 
environmental factors like diet and medication [5]. The important differences between a stable 
bacterial community and one that is unstable are that a stable community has a significant 
amount of functional redundancy [6] and an ability to effectively revert to the previous 
community dynamics after a perturbation [7]. These observations should expand our 
understanding of gut homeostasis to not only refer to the dynamic cross-talk between host tissues 
and the microbiota to effectively limit inflammation, but to also encompass host mechanisms that 
allow the microbiota to remain stable over time. However, little is known about the mechanisms 
that maintain temporal community stability or allow for effective recovery after an 
environmental perturbation.  
Immunoglobulin A (IgA) is the most abundant antibody produced in mammals, and the 
majority of IgA is secreted across mucus membranes, such as the lining of the gastrointestinal 
tract [8, 9]. IgA protects the host through a multitude of mechanisms, including inhibiting host 
absorption of immunogenic particles like toxins and viruses [10-12] and interference with 
microbial adherence to the epithelium [13]. IgA is also argued to aid in the establishment and 
temporal stability of the commensal microbiota through such functions as assistance in biofilm 
development [14, 15]. The relationship between IgA and the commensal microbiota has received 
little attention, but the status of IgA deficiency as the most common primary immunodeficiency 
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in humans, coupled with the high incidence of infection and allergy in individuals with this 
deficiency [16], points to the value of investigating this host-microbe relationship.   
IgA recognition of the commensal microbiota is a normal mechanism in mammalian 
physiology and between 24-74% of fecal bacteria are coated with IgA in healthy humans [17]. 
Attempts to correlate IgA coating frequency of the commensal microbiota with various states of 
health suggest that IgA coating is elevated in inflammatory bowel disease and reduced in 
irritable bowel syndrome [18], while lifestyle changes resulting in weight loss are also reported 
to reduce IgA coating frequency [19]. A decreased frequency of IgA coating of bacteria may 
indicate that the host immune reponse is underactive, which could correlate with increased 
susceptibility to pathogens. Conversely, a high frequency of IgA coating may indicate an 
overactive immune system that mounts defenses unnecessarily against commensal bacteria, food 
antigens, or even self-antigens. However, the frequency of bacteria coated with IgA in these 
disease states is still within the range reported for healthy individuals, so it is unlikely that such 
measurements are of clinical significance on their own. A healthy host-microbiota interaction is 
likely to include elements of immunological tolerance to antigens as well as directed and 
preferential IgA coating [20], which suggests that the types of bacteria or bacterial antigens 
coated with IgA are more indicative of disease state than is the total proportion of the microbiota 
coated with IgA.  
Several findings indicate that the absence of TLR5 causes profound alterations in host 
IgA, such as significantly increased IgA production [21], decreased anti-flagellin IgA (Chapter 
1), and an impaired T cell response to flagellin [22]. Furthermore, TLR5-/- mice exhibit a 
compensatory upregulation of TLR4 [23], which indirectly spurs a further increase in IgA 
production [24]. These observations suggest that TLR5 is critical not only to the effective 
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production of anti-flagellin IgA but also other components of the IgA repertoire and their 
relationship with the commensal microbiota. If the development of gut inflammation observed in 
TLR5-/- is due not only to their inability to manage bacterial flagellin production but also 
improper interactions between IgA and the gut commensal microbiota, this mouse model might 
exhibit an immune defect applicable to a whole host of gastrointestinal disorders. 
In this study, I investigate the implications of IgA deficiency on the composition of the 
gut bacterial community as well as the community’s temporal stability and response to 
perturbation. A two month time course of 16S rRNA-based sequencing and analysis was 
performed on the gut microbiota of RAG1-/- mice, which cannot produce T cells or B cells, and 
thus do not produce antibodies. In addition to quantifying the temporal stability of the gut 
microbiota of these mice, the antibiotic clindamycin was administered for a portion of the time 
course in order to investigate how well the bacterial community recovers from environmental 
perturbation. Finally, I used fluorescence activated cell sorting (FACS) combined with 16S 
rRNA pyrosequencing to compare the IgA-bound gut bacterial population to the population not 
bound to IgA, and how these two fractions of the microbiota differ between WT and TLR5-/- 
mice. 
  
 
3.3 Results and Discussion 
To gain a better understanding of the influence of the host’s adaptive immune system on 
the composition, stability, and resilience of the gut microbiota, I performed a 16S rRNA-based 
analysis of the fecal pellets of RAG1-/- mice and age-matched WT mice over the course of two 
months. These mice were maintained by Daniel Peterson at the University of Nebraska–Lincoln. 
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A UniFrac principal coordinates analysis (PCoA) plot, which measures the phylogenetic 
similarity between communities based on sequence divergence, reveals that the two mouse 
genotypes harbor fecal microbiotas that do not clearly segregate (Figure 1). Curiously, the 
microbiotas of RAG1-/- and WT mice begin to diverge after the twelfth time point and this 
divergence is also apparent in the cecal contents that were collected at the end of the study. The 
divergence does not appear to be genotype specific, but, rather, the bacterial communities of both 
genotypes shift in similar directions. On the date of the twelfth time point there was heavy 
building construction close to the housing facility (introducing noise and vibration) as well as the 
weekly cage change and a thorough floor washing of the facility. This collection of disturbances 
may have been sufficient to profoundly alter the composition of the gut bacterial community. 
Since these factors cannot be defined or quantified, these confounding time points after the 
eleventh fecal collection were excluded from downstream analysis.  
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Figure 1. Principal coordinates analysis of 16S rRNA sequences does not clearly segregate 
the gut bacterial communities of RAG1-/- mice and WT mice. The first three principal 
coordinates (PC1, PC2, PC3) from the principal coordinates analysis constructed from the 
unweighted UniFrac are plotted for each sample. Each dot represents the bacterial community at 
a particular time point and is labeled as ‘time point.mouse number’ for RAG1-/- (orange) or WT 
(green). The variance explained by the PCs is indicated in the parentheses on the axes. 
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 To investigate how the gut microbiota respond to a defined perturbation in the absence of 
the host’s adaptive immune system, clindamycin was administered subcutaneously for four 
consecutive days, beginning on time point seven. I chose clindamycin because administration of 
this antibiotic is often associated with post-therapeutic Clostridium difficile infection and colitis 
in clinical settings [25], suggesting that clindamycin is a good candidate for studying 
perturbation and resiliency of the microbiota. It is unlikely that clindamycin was responsible for 
the dramatic shift in the microbial communities that was observed after time point twelve 
because two weeks separate the first antibiotic administration and the dramatic community shift, 
which would be an extremely delayed onset for clindamycin [26, 27]. The antibiotic did not 
appear to alter the bacterial community dramatically based on the similar UniFrac distances and 
phylum compositions before and after administration of clindamycin (Figure 1, Figure 2), but 
administration did correspond with an increase in the frequency of Proteobacteria. Further, the 
increase in Proteobacteria was significantly greater in RAG1-/- mice than in WT mice (p = 
0.013, paired 2-tailed t-test). Interestingly, many γ-Proteobacteria including the genera 
Pseudomonas and Enterobacter show resistance to clindamycin [28, 29], which may explain 
why this phylum was able to expand its presence in the community following the antibiotic 
challenge. None of the other phyla were significantly different between the mouse genotypes 
before or after the antibiotic challenge. An expansion of Proteobacteria in the gut microbiota has 
been repeatedly observed in numerous intestinal disorders [30], even when a pathogen cannot be 
identified or the pathogen does not belong to the Proteobacteria phylum [31, 32]. These findings 
suggest that Proteobacteria are particularly adept at expanding during or following gut 
perturbations and the inability of a host to manage populations of commensal Proteobacteria 
could be indicative of a disease state. 
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Though I did not directly measure the functional stability of the gut microbiota of  
RAG1-/- mice and WT mice over time, I did calculate the Gini coefficient of these communities. 
The Gini coefficient is a metric of community evenness, with lower numbers representing 
increasing evenness. Previous studies of bacterial communities have used this metric and found 
that increased community evenness correlates well with functional stability [33, 34], suggesting 
that the gut microbiota of a healthy host should have a lower Gini coefficient compared to the 
microbiota of diseased or immunocompromised hosts. Indeed, the Gini coefficient of the 
microbiota of RAG1-/- mice is significantly higher than the microbiota of WT mice (p= 0.008, 
paired 1-tailed t-test), especially after the administration of clindamycin (p=0.004, paired 1-tailed 
t-test), (Figure 3). Thus, I observed that higher evenness and stability of the gut microbiota was 
associated with healthy WT mice, while reduced evenness and stability of the gut microbiota was 
associated with RAG1 immunodeficiency, which predisposes the host to disease symptoms such 
as chronic skin inflammation and granuloma development [35].  Therefore, these data suggest 
that the adaptive immune system is critical to maintaining a gut microbiota that is both 
functionally stable and more resistant to perturbation—two characteristics of healthy 
communities. In this sense, a properly functioning immune system is critical not only to 
protection from pathogenic insult, as conventional understanding holds, but also to maintaining 
community evenness of the gut microbiota as a means of minimizing damage from 
nonpathogenic environmental changes. 
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Figure 2. 16S rRNA-based composition of the gut microbiota at the phylum level reveals an 
increased frequency of Proteobacteria in RAG1-/- mice compared to WT mice. The 
percentages of the community comprised of each of the listed phyla at each time point 
(abbreviated as TP) are represented by the variously colored bars (mean ± se), with RAG1-/- 
mice above and WT mice below.  
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Figure 3. The community evenness of the gut microbiota of RAG1-/- mice is 
significantly lower than in WT mice over time. The Gini coefficient is represented on the y-
axis, with lower values representing increased evenness. The Gini coefficient is given at each 
time point for RAG1-/- mice (red squares) and WT mice (blue diamonds) as means ± se. 
 
  
 64 
 
I previously showed that TLR5-/- mice have an aberrant IgA response that is 
characterized by increased IgA production and reduced anti-flagellin IgA (Chapter 1). Since IgA 
is implicated in gut homeostasis and the maintenance of a commensal microbiota [14, 15] and 
TLR5-/- mice display a temporally unstable gut microbiota [36], I wanted to investigate the 
possibility that the IgA repertoire of TLR5-/- mice interacts with the gut microbiota in a different 
manner than in WT mice. To do this, I first assessed the proportion of the bacterial biomass 
coated by IgA in TLR5-/- and WT mice by sorting cecal bacteria into IgA-coated (IgA+) and 
uncoated (IgA-) fractions using fluorescence-activated cell sorting (FACS), (Figure 4) [17]. The 
proportion of IgA+ bacteria was similar for TLR5-/- and WT (21.7%±5.9 vs. 18.8%±4.2, 
n=4/group, n.s.). This suggests that, despite the discrepancies in IgA production between TLR5-
/- and WT mice, the gut microbiota is equally bound with IgA in both mouse types. However, 
this data does not provide information on the average number of IgA molecules bound to each 
IgA+ bacterial cell, the epitopes recognized by IgA and their binding affinity, or the taxonomy of 
the IgA+ and IgA- bacteria.  
As a gross comparison of the specificity of IgA from the TLR5-/- and WT hosts, I 
incubated IgA derived from the intestines of these mice with a bacterial biomass previously 
unexposed to IgA (derived from RAG1-/- mice).  Results indicate that IgA from TLR5-/- and 
WT mice is equivalently able to bind the bacteria derived from RAG1-/- mice (55.7%±7.8% and 
50.1%±7.8% of cells, respectively, n=4/group, n.s.). This relatively crude assay suggests that IgA 
produced by TLR5-/- is sufficiently able to recognize and bind a portion of the microbiota 
similar to what is observed in WT mice. 
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Figure 4. Proof of concept for fluorescence activated cell sorting of IgA-coated bacteria. I 
recovered bacteria from the cecal contents of a WT mouse via selective centrifugation and 
incubated with a FITC-labeled anti-mouse-IgA antibody. (A) Propidium iodide (PI) was used as 
an indiscriminate bacterial stain and (B) cells were separated based on the exhibition of FITC/PI 
fluorescence. Top: dot plots represent 10,000 recorded events. Q1: PI positive (IgA- cells); Q2: 
PI/FITC positive (IgA+ cells); Q3: PI/FITC negative (debris); Q4: FITC positive (IgA+ debris). 
Bottom: histograms represent count-binned FITC fluorescence.  
  
 66 
 
To gain a more detailed understanding of how loss of TLR5 signaling impacted the 
specific suite of bacteria coated in IgA, I profiled the bacterial diversity of cell-sorted IgA+ and 
IgA- cells isolated from the cecal contents of TLR5-/- and WT mice using pyrosequencing of 
16S rRNA genes. Since TLR5-/- mice have an immune deficiency and also display increased 
inflammatory markers [23, 37], I also included MyD88-/- mice and DSS-treated WT mice in this 
assay to better discriminate between the effects of immune deficiency (MyD88-/-) and 
inflammation (DSS-treated). Patterns of bacterial coating were similar for TLR5-/- and  
MyD88-/- mice, and DSS-treated mice were similar to WT mice (with the exception of 
Bacteroidetes, which is a nonflagellated phylum), (Figure 5A). These findings indicate that 
differences in IgA-coated populations were attributable to impaired TLR5 signaling rather than 
inflammation. A previous study found that, in healthy mice and humans, Enterobacteriaceae 
(Proteobacteria) is preferentially frequently coated with IgA in the gut while Lactobacillus and 
Enterococcus (both Firmicutes) were poorly coated [38]. This pattern agrees with my findings of 
IgA coating in WT mice with or without DSS treatment, while TLR5-/- mice exhibit the opposite 
pattern. Further, the similarities in phylum composition between TLR5-/- and WT mice (Figure 
5B) indicate that the differences in IgA-coated populations are due to an altered IgA repertoire 
and not simply to differences in the bacterial community. Notably, TLR5-/- mice showed an 
enrichment of IgA-coated Firmicutes and a depletion of IgA-coated Proteobacteria, even though 
both of these phyla contain many flagellated species. It is possible that the reduced IgA coating 
of Proteobacteria in TLR5-/- mice is a factor that allowed this phylum to expand its population in 
these mice. If Proteobacteria are less bound by IgA and their flagellar motility is not inhibited by 
the immune system, they may be able to extract more nutrients and occupy a wider range of sites 
in the gut. This may be why I see Proteobacteria penetrating the villi of the small intestine and 
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deep into the mucosal layer in the colon of TLR5-/- mice (Chapter 3). It is also possible that 
Proteobacteria are actively downregulating epitopes targeted by the IgA of TLR5-/- mice in a 
similar fashion to what has been observed for Bacteroidetes thetaiotaomicron and S. 
Typimurium [39, 40]. Despite the differences observed between the IgA+ and IgA- fractions of 
the gut microbiota of these mice, the community diversity of these two fractions still cluster most 
tightly by individual mouse in a PCoA of the UniFrac distance matrix (Figure 5C). If the antigen 
specificities within the IgA repertoire were highly similar for a given mouse genotype, then I 
would expect the IgA+ fraction of the community to cluster together for that genotype. 
If IgA were coating gut bacteria indiscriminately, as is argued by the “natural” IgA 
hypothesis that IgA in the lumen is spontaneously generated without affinity towards particular 
antigens [41], then one would expect the increased gut IgA of TLR5-/- mice [21] to correspond 
to an increased proportion of all microbiota coated in IgA. However, I did not observe this, and 
more recent work refutes the claim of “natural” IgA, finding that most IgA in the gut is actually 
antigen-specific [42]. These findings indicate that the role of IgA in gut homeostasis is more 
nuanced than its mere presence or abundance in the intestine. In fact, the average number of IgA 
molecules secreted into the human gut each day is calculated to be 10
7
-fold higher than the total 
number of commensal intestinal bacteria [43] and less than 5% of these IgA molecules are 
actually bound to bacteria [44]. My observation that anti-flagellin antibodies are sufficient to 
cause bacterial downregulation of flagellin (Chapter 1), coupled with other recent findings of 
bacteria decreasing antigen expression in direct response to antibodies specific for that antigen 
[39, 40], suggests that IgA may have profound implications for gene regulation of the gut 
microbiota at a broad level. 
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Figure 5. Effect of TLR5 signaling on IgA coating of bacterial populations. (A) Box plots 
represent the ratio of IgA-coated to non-IgA-coated cecal bacteria for the specified dominant 
bacterial phyla. A value of 1 indicates equal frequencies of IgA-coated and non-IgA coated 
bacteria in a particular phylum. N = 4 mice/group; *P < 0.05, two-tailed t-test; n.s., 
nonsignificant. (B) Bar graphs of the average composition of cecal bacteria for each genotype, 
with sequences pooled from IgA-coated and non-IgA-coated bacteria. Phylum key is on the 
right. (C) PCoA of the weighted UniFrac distance matrix using 16S rRNA sequences from IgA-
coated to non-IgA-coated cecal bacteria of TLR5-/- (blue) and WT (green) mice. The first three 
principal coordinates (PC1, PC2, PC3) are plotted. Each dot represents either the IgA+ or IgA- 
fraction of the bacterial community for a particular mouse. The variance explained by the PCs is 
indicated in the parentheses on the axes. 
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If IgA binds widely to shared antigens, the coating frequency of bacterial genera is 
expected to be proportional to their abundance in a stepwise fashion [45]. This was the case for a 
majority of taxa, although a few outliers with high abundances were either more or less coated 
than expected, as calculated by Cook’s distance (Figure 6). Several operational taxonomic units 
(OTUs) classified as bacteria of the Bacteroidetes phylum were consistently highly coated with 
IgA in WT and TLR5-/- mice, while OTUs classified as bacteria of the Firmicutes phylum 
tended to be less coated with IgA in WT mice only. Despite containing many flagellated species 
and exhibiting expansion in the gut microbiota of TLR5-/- mice [36, 46], no particular γ-
Proteobacteria displayed significantly aberrant IgA coating profiles in either mouse genotype. 
Interestingly, an OTU classified as Alcaligenaceae, which is within the β-Proteobacteria phylum 
and contains many flagellated members, was highly coated in WT mice but not TLR5-/- mice. 
Conversely, an OTU classified within the δ-Proteobacteria phylum as Desulfovibrio and an OTU 
classified within the ε-Proteobacteria as Helicobacteraceae, both of which are flagellated, were 
significantly highly coated and less coated in the TLR5-/- mice, respectively. These results 
suggest that, while the taxonomic profiles of IgA-bound bacteria do not largely differ between 
TLR5-/- and WT mice, there are still significant discrepancies in the frequency of IgA coating of 
specific OTUs. 
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Figure 6. Effect of TLR5 signaling on IgA coating of bacterial populations. (A) The 
normalized abundance of 16S rRNA gene sequences from IgA+ bacterial cells are plotted against 
abundances for IgA- cells for the 25 most abundant genera. The 2 most abundant genera in each 
mouse phenotype are labeled. (B) Taxonomic classification of genus-level OTUs (97%ID) with 
significantly aberrant IgA-coating frequencies (based on Cook’s distance, See Methods). 
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2.4 Conclusion 
These findings indicate that hosts need to develop an effective IgA repertoire with a 
broad range of antigen specificities in order to maintain temporal stability and resilience of their 
commensal gut microbiota. Consistent with previous surveys of the microbiota of TLR5 mice, I 
found that the guts of TLR5-/- mice are slightly enriched in Proteobacteria and are more 
temporally unstable [36, 37].  I also found that the microbiota of RAG1-/- mice were more 
temporally unstable and exhibited reduced community evenness compared to the microbiota of 
WT mice.  Thus, the temporal instability of the TLR5-/- mice may be linked to their inability to 
manage Proteobacteria populations [36], and this may be due to their reduced ability to coat 
these bacteria with IgA. IgA titers and bacterial biomass were previously reported to be higher in 
TLR5-/- mice [21, 37]. My results generally support the view that IgA induction functions as a 
stepwise response tailored to bacterial load because most bacteria were equally represented in the 
IgA-coated and non-IgA-coated fractions [45], but they also show that specific bacterial species - 
particularly, abundant ones - can evade IgA coating in the gut. 
I found that the IgA from TLR5-/- and WT mice coated the same proportion of a naïve 
microbiota previously unexposed to IgA.  The IgA produced by these two hosts has been trained 
on gut microbial communities that differ in the following ways: (1) greater overall abundance in 
TLR5-/- mice and (2) slight enrichment of Proteobacteria in TLR5-/- mice.  I found that the 
Proteobacteria generally evade IgA coating, despite increased abundance in the TLR5-/- mice. 
This suggests that the repertoire of IgA specificities is different between TLR5-/- and WT mice. 
Alternatively, it is possible that Proteobacteria are more actively downregulating expression of 
surface antigens that are recognized by the IgA repertoire of the TLR5-/- mouse. In summary, 
these results support the view that antibody coating of bacteria is a fundamental component of 
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homeostasis in the mammalian gut due to the increased temporal stability and resilience that 
result from microbe-antibody interactions.  
 
2.5 Materials and Methods 
Animal experiments: All mice used in this study were C57BL/6 strain. All mice used in the 
timeline study were maintained at University of Nebraska—Lincoln and all mice used in FACS 
analyses were maintained at Emory University. All animal experiments were approved by the 
local IACUCs. For the timeline study involving RAG1-/- and WT mice, fecal pellets were 
collected approximately every five days for two months and mice were subcutaneously injected 
with 8 mg of clindamycin phosphate (Hospira, Inc., Lake Forest, IL) suspended in 0.2 ml of 
sterile saline (Bimeda – MTC Animal Health, Inc., Cambridge, Ontario). This work was 
performed by Clindamycin was administered for four consecutive days beginning on the day of 
the seventh fecal collection. For DSS treatment, C57BL/6 WT mice were administered 2.5% 
DSS (MBL Biomedicals) in drinking water for 7 days immediately preceding sample collection. 
 
Sorting of IgA-coated bacteria:  Four age/gender matched 8-week old TLR5-/-, MyD88-/-, WT 
DSS-treated, and WT mice were sacrificed and their ceca were immediately removed and snap 
frozen in liquid N2. I prepared cecal contents for FACS of IgA-coated bacteria as described using 
methods in (25). Briefly, I suspended cecal contents of mice in 4.5 ml PBS, homogenized on a 
vortex mixer on high for 2 minutes, and centrifuged at low speed (40g, 20 minutes) to separate 
larger cecal particles from bacteria. I removed the resulting supernatant and centrifuged at 
8,000g for 10 minutes and discarded the supernatant in order to remove non-bound IgA. I then 
resuspended each bacterial pellet in 2 ml of PBS containing 1% weight/volume of BSA with or 
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without FITC-labeled goat F(ab’)2 anti-mouse IgA (Sigma, St. Louis, MO) and incubated for 1 
hour. I washed suspensions and resuspended in 2 ml of PBS with or without propidium iodide 
(PI, 100 mg/l) as an indiscriminate marker for all bacteria. Samples were stored on ice in the 
dark and analyzed within 2 hours. 
 
I performed flow cytometry with a BD-Biosciences FACS Aria high speed flow cytometer/cell 
sorter utilizing a quartz cuvette for interrogation. Fluorophore excitation was performed by an 
Argon laser operating at 15 mW and 488 nm. Filter settings were 525 BP for FITC, 550 LP and 
630 BP for measurement of PI. Standard ELITE software comprising the Immuno-4 program 
was used to determine the percentage of stained events. The discriminator was set on PI 
fluorescence as a specific probe for bacteria. The discriminator value was determined by a 
filtered, bacteria-free (0.22 μm Millipore, Molsheim, France) solution of PI / PBS (4 mg/l) and 
set at a level with minimal background noise. I analyzed a portion of each sample incubated with 
PBS (background fluorescence) and a portion incubated with FITC-labeled goat F(ab’)2 anti-
mouse IgA. Both measurements were performed with a minimum of 10,000 events, at a flow rate 
of 1000 - 1500 events/sec. The percentages of stained bacteria were determined with Immuno-4 
software (Coulter). Sorting experiments were performed with gates on FSC > 1000 and on FSC 
< 1000 in combination with gates on side scatter or PI. Furthermore, I performed a sorting 
experiment with a FSC – FITC fluorescence gate to isolate a strongly IgA-coated bacterial 
population. The cell sorter collected a minimum of 500,000 cells of each category (IgA-bound 
and non-bound). 
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16S rRNA gene sequencing and analysis: I extracted bulk DNA from the fecal pellets of mice 
used in the time course study with the PowerSoil DNA isolation kit as described by the 
manufacturer (MoBio Laboratories Ltd, Carlsbad, CA) and using a Mini-Beadbeater-24 
(BioSpec, Bartlesville, OK) set on high for 2 minutes. I extracted bulk DNA of the FACS-sorted 
cells (see above) using a similar process except with a more appropriate kit: the PowerWater 
DNA isolation kit as described by the manufacturer (MoBio Laboratories Ltd, Carlsbad, CA). I 
amplified bacterial 16S rRNA genes from each sample using the 27F and 338R primers for the 
V1-V2 hypervariable region of the 16S rRNA gene (26). Primers included unique error-
correcting 12-base barcodes used to tag PCR products from different samples (27). PCR 
reactions consisted of 2.5U Easy-A high-fidelity enzyme and 1X buffer (Stratagene, La Jolla, 
CA), 200 nM of each primer, and 2-3 ng DNA template; reaction conditions consisted of an 
initial denaturing step for 2 minutes at 95°C, followed by 32 cycles of 40 seconds at 95°C, 30 
seconds at 57°C and 60 seconds at 72°C. I performed triplicate PCR reactions for each sample, 
combined and then purified with Ampure magnetic purification beads (Agencourt, Danvers, 
MA). I quantified the clean PCR products using a Quant-iT PicoGreen dsDNA assay (Invitrogen, 
Carlsbad, CA). I had the pooled products sequenced at the Core Laboratories Center at Cornell 
University using the Roche 454 FLX platform.  
 
For quality filtering I discarded sequences <200 bp or >1,000 bp, and ones containing >0 primer 
mismatches, uncorrectable barcodes, >0 ambiguous bases, or homopolymer runs in excess of 6 
bases, using the open source software package Quantitative Insights Into Microbial Ecology 
(QIIME) (28). I checked sequences for chimeras (UCHIME) and assigned sequences to 
operational taxonomic units (OTUs) using Otupipe (29) with a 97% threshold of pairwise 
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identity, and then classified them taxonomically using the Greengenes reference database (30). I 
rarified samples to 7,000 reads per sample, calculated the ratio of IgA+ : IgA- for each OTU, and 
calculated Cook’s distance in R to find OTUs with IgA coating ratios that diverged significantly 
from the mean (31). 
 
Statistics: I performed statistical analyses and linear regression analysis in Microsoft Excel 
2011, StatPlus 2009, and R version 2.11.1. Statistical tests were paired student ‘t’-test, unpaired 
student ‘t’-test, Cook’s distance, and Gini coefficient, as indicated. Significance level of p<0.05 
unless otherwise indicated. All multiple comparison testing was accounted for with Bonferroni 
correction. 
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CHAPTER 3 
 
TLR5-/- MICE DISPLAY REDUCED INTEGRITY OF THE GUT MUCOSAL BARRIER AND AN 
INABILITY TO QUENCH BACTERIAL MOTILITY  
 
4.1 Summary 
 The maintenance of separation between host tissues and the bacterially dense intestinal 
lumen is critical to host health. Immunoglobulin A (IgA), Toll-like receptor 5 (TLR5), and a 
physical barrier of mucus are all important in preventing bacterial pathogens from invading host 
tissues, but it is unclear how these mechanisms interact with the comparatively abundant and 
persistent commensal microbiota. Here, I use a combination of fluorescent in situ hybridization 
and immunohistochemistry to show that the intestinal microbiota of TLR5-/- mice invades the 
inner mucus layer of the colon and that flagellated bacteria are in direct association with the 
epithelium, despite increased secretion of IgA. Flagellin purified from an assortment of 
commensal Firmicutes revealed that many members of this phylum produce flagellins with 
TLR5 stimulatory capacity equal to that of γ-Proteobacteria. An antibody developed against a 
representative flagellated commensal Firmicutes, Roseburia hominis, displayed cross reactivity 
by binding to multiple flagellin proteins derived from both Firmicutes and γ-Proteobacteria. 
These results suggest that TLR5 is critical to the proper functioning of the mucosal barrier and 
development of an anti-flagellin IgA repertoire. In the absence of TLR5, it appears that the 
commensal bacteria increase their motility and penetrate host tissues without impedance from 
anti-flagellin IgA. 
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4.2 Introduction 
 The mammalian gut is densely populated by bacteria that are essential to host 
metabolism, the vast majority of which reside in the colon. When the gut epithelium is properly 
functioning, hosts are able to maintain a symbiosis with their resident microbiota without 
overstimulation of the innate and adaptive immune systems [1]. The mechanisms by which host 
tissues are healthily maintained in such close proximity to bacteria are not completely 
understood, though it has been recognized that mucus, IgA, and TLRs all play critical roles [2-4]. 
Through these interactions, commensal bacteria are maintained on the luminal side of the host-
derived mucus layer. 
 Mucus not only provides a physical barrier to protect the host, but also serves as a 
colonization site [3] and nutrient substrate [5] for much of the gut bacterial community. The 
mucus layer in the small intestine is relatively thin, so as not to impede nutrient absorption, and 
must be bolstered by antibacterial peptides and fast peristalsis in order to prevent bacterial 
penetration [6, 7]. Conversely, colonic mucus is approximately 4-5 times thicker and maintains a 
dense inner layer that tightly adheres to the epithelium and is impervious to bacteria [3, 6]. 
Mucus in the small intestine and colon is comprised largely of the mucin protein MUC2, which 
is produced by goblet cells that reside at the base of epithelial crypts [8]. Colonic MUC2 forms a 
dense polymer that expands and becomes more permeable over time, which results in a stratified 
mucus layer that provides a habitat for bacteria in the less dense layer while still protecting the 
epithelium [9]. Mice deficient in MUC2 display inflammation and cancer development that 
stems from constant bacterial contact with the epithelium and invasion of epithelial crypts [3].  
 Secretory IgA serves as an additional mechanism in maintaining barrier protection 
between host tissues and the gut microbiota. The reported actions of IgA in the intestinal lumen 
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are myriad and include entrapment of bacteria in the mucus layer and hindering bacterial 
association with the epithelial cell surface [10]. Hence, secretory IgA is generally associated with 
protecting the host from bacterially induced harm in a process termed ‘immune exclusion’. For 
example, mice with genetic IgA deficiency undergo an excessive expansion of anaerobic bacteria 
that results in an exaggerated immune response and hyperplasia of isolated lymphoid follicles [2, 
11, 12]. However, evidence suggests that secretory IgA may play a much broader role in 
maintaining health by aiding commensal bacteria in colonization and increasing resiliency of the 
gut community to perturbation [13, 14]. Some gut bacteria reduce their expression of IgA 
binding proteins when growing in IgA-deficient hosts, suggesting that there may be selection 
pressure in the healthy gut for commensal bacteria that are able to bind IgA [15]. Further, 
secretory IgA was found to facilitate biofilm formation when microbial communities from 
healthy individuals were cultured on epithelial cells under conditions in which non-adherent 
bacteria were continuously washed away [13].   
 The innate immune system comprises the third major mechanism by which hosts 
maintain a barrier of protection between themselves and their gut microbiota. It relies on the 
recognition of microbial structures that are evolutionarily conserved and not represented in the 
host. In the case of TLR5, this recognized structure is the highly conserved D1 domain of the 
flagellin protein, which is required for flagellar protofilament assembly and thus, bacterial 
motility [16, 17]. However, several bacterial taxa, including the often pathogenic α- and ε-
Proteobacteria, contain alternative residues in the D1 domain that allow them to evade TLR5 
recognition [18]. Conversely, many species of the Lactobacillus genus that are regularly 
employed in food and probiotic applications produce flagellin proteins that are fully capable of 
stimulating TLR5 [19]. This suggests that TLR5 is unable to discriminate between flagellin 
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derived from pathogens and flagellin derived from commensal or symbiotic bacteria. The 
majority of flagellated commensal gut bacteria have not been assessed for their ability to 
stimulate TLR5, so it is unclear how this potential shortcoming of TLR5 affects gut health. 
Stimulation of TLR5 is an important factor in the development of flagellin-specific adaptive 
immunity [20], so an inability to discern between pathogenic and commensal bacteria may also 
have important implications in the development of an anti-flagellin IgA repertoire.    
 I have previously shown that TLR5-/- mice have an overly flagellated microbial 
community and that anti-flagellin IgA, which I argue to be responsible for reducing bacterial 
expression of flagella, is deficient in TLR5-/- mice (Chapter 1). However, it is unclear how these 
traits manifest at the mucosal interface. It is also unknown if flagellin proteins from 
taxonomically distinct commensal bacteria stimulate TLR5 to the same magnitude as more 
thoroughly studied pathogens. Here I use fluorescent in situ hybridization (FISH) and 
immunohistochemistry techniques to investigate the spatial organization of bacteria and host 
tissues, as well as flagellin and IgA, in situ, in an effort to better understand how the lack of 
TLR5 alters the integrity of the mucosal barrier. I also work to expand our understanding of the 
role of anti-flagellin IgA in gut homeostasis beyond its effects on γ-Proteobacteria to better 
understand how these antibodies affect Firmicutes, the most abundant flagellated phylum in the 
gut. I explore the cross-reactivity of commercial anti-flagellin antibodies as well as the potential 
of antibodies derived from healthy mice to bind various bacterial flagellins. Lastly, I use time-
lapse microscopy to better understand the motility of the gut microbiota of TLR5-/- mice and 
how the presence of anti-flagellin antibodies affects motility within this mixed community as 
compared to pure cultures.  
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4.3 Results & Discussion 
 To better understand how the increased bacterial load, increased flagellin load, and 
altered SIgA specificity of TLR5-/- mice manifest in the gut, I first performed FISH microscopy 
in which I probed for 16S rRNA of the domain Bacteria. The images reveal that the colon of WT 
mice has a distinct layer of mucus that is populated by few to no bacteria and is generally absent 
or markedly reduced in the TLR5-/- mouse colon (Figure 1). Thus, bacteria in the colon of 
TLR5-/- mice appear to heavily infiltrate right up to the epithelial edge of the mucus layer. 
Previous studies suggest that the colonic inner mucus layer in healthy mice is approximately 50 
µm thick [3, 21], which agrees with my findings. This layer of mucus has been repeatedly 
observed in the colons of healthy mice and humans and absent or depleted in individuals with 
inflamed colons [3, 22, 23]. However, few studies have directly addressed whether reduced 
mucosal integrity is a cause or an effect of gut inflammation. Mice treated with dextran sodium 
sulfate (DSS) develop an impaired mucosal barrier within 3-5 days but display gut inflammation 
only after bacteria have penetrated the mucus [24], suggesting that reduced mucosal integrity is a 
cause of inflammation. Also, mice housed in germ-free conditions do not have elevated 
inflammatory markers despite a comparatively thin mucus lining of the colon [25]. The thin 
mucus layer is restored to typical thickness upon exposure to bacterial peptidoglycan or 
lipopolysaccharide [25], indicating that a commensal gut microbiota can actually help to 
maintain the mucus lining in healthy hosts. Both of these findings suggest that the increased 
inflammatory markers observed in TLR5-/- mice [26, 27] are initially caused by the highly 
flagellated microbiota rather than an aberrant mucus layer. 
A subset of TLR5-/- mice has been found to spontaneously develop colitis [27], though 
we have not observed colitis in TLR5-/- mice housed at Cornell University. Recent FISH studies 
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of TLR5-/- colonic tissues have revealed that colitic mice have an intact, though relatively thin, 
inner mucus layer, but that this layer was penetrated by bacteria [22]. Conversely, the colons of 
non-colitic TLR5-/- mice in the study displayed a relatively intact mucus layer without bacterial 
penetration. Insufficient information is provided about the mice used in the study to provide an 
explanation for the differences in mucosal integrity between our TLR5-/- mice and those used by 
Johansson et al. [22]. However, the composition of the gut microbiota of mice is heavily 
influenced by their housing facility [28], which may explain why our TLR5-/- display a defective 
mucosal barrier but fail to develop colitis. 
The small intestines of TLR5-/- mice revealed assemblages of bacteria invading the villi 
– these groups were completely absent in WT mice. To further investigate the type of bacteria 
present in these assemblages, I used probes specific for γ-Proteobacteria as well as the phyla 
Firmicutes and Bacteroidetes (Figure 2). The differential probes revealed that γ-Proteobacteria 
were responsible for the vast majority of observed invading bacteria. In several occurrences, the 
invading γ-Proteobacteria were found to co-occur with Firmicutes. The penetration of bacteria 
into the small intestines of TLR5-/- mice further suggests that these mice have an insufficient 
mucosal barrier. The co-occurrence of γ-Proteobacteria and Firmicutes in the breach of the small 
intestine agrees with the inability of previous studies to identify a specific pathogen responsible 
for the TLR5-/- phenotype [26, 29] and bolsters the idea that metabolic syndrome and 
inflammation correlates with a broad shift in the activity of the gut microbiome – namely, an 
increase in flagellar motility in at least two prominent phyla.  
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 Figure 1. The large intestine of TLR5-/- mice lacks mucosal integrity and displays 
increased bacterial penetrance. Each panel displays a fluorescent micrograph of a separate 
mouse large intestine section, with TLR5-/- mice (LEFT) and WT (RIGHT) shown. The images 
are positioned with host tissues on the left and the lumen on the right. BLUE: Nuclei of cells 
comprising host villi are stained with Hoechst 33342. GREEN: bacterial cells imaged by in-situ 
fluorescent hybridization using fluorescently labeled oligonucleotides probes specific to the 
Domain Bacteria (EUB338). Food particles in the lumen display autofluorescence and may 
fluoresce blue due to DNA content. Red brackets annotate the bacterially sparse inner mucus 
layer of WT mice that is absent in TLR5-/- mice. The top and bottom panels show two examples 
in each genotype and the scale bar applies to all images. 
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Figure continued on following page. 
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Figure 2. γ-Proteobacteria and Firmicutes display increased penetrance of the small 
intestine of TLR5-/- mice. Each panel displays a fluorescent micrograph of a separate mouse 
small intestine section with TLR5-/- (LEFT) and WT (RIGHT) shown. BLUE: Nuclei of cells 
comprising host villi are stained with Hoechst 33342. GREEN: bacterial cells imaged by in situ 
fluorescent hybridization using fluorescently labeled oligonucleotides probes specific to the 
phylum γ-Proteobacteria (GAM42a). ORANGE: bacterial cells imaged by in situ fluorescent 
hybridization using fluorescently labeled oligonucleotides probes specific to the phylum 
Firmicutes (LGC354a-c). The co-occurrence of γ-Proteobacteria and Firmicutes appears as 
white. Bacterial clusters are labeled with red arrows. The top and bottom panels show four 
examples in each genotype and the scale bar applies to all images. 
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Measurements taken from the cecal contents and fecal pellets of TLR5-/- mice indicate 
that total IgA is significantly elevated compared to WT levels (Chapter 1). To better understand 
the location and bearing of secretory IgA, I performed immunohistochemistry with antibodies 
targeting mouse IgA in the large intestine. In agreement with previous observations, TLR5-/- 
mice appear to have more total IgA present in the lumen (Figure 3). In both mouse types IgA 
appears dispersed and lacks noticeable patterning at the mucosal interface, except for the 
appearance of subepithelial host cells that present strong IgA signal and are likely IgA-producing 
plasma cells. If TLR5-/- mice have impaired mucosal barrier function, as suggested, it is likely 
that their immune system encounters significantly more bacterial products as well as other 
luminal contents. The development of immune tolerance is not well understood, but it’s possible 
that insufficient tolerance against luminal antigens is responsible for increased production of 
secretory IgA in TLR5-/- mice. It’s also possible that the TLR5-/- immune system attempts to 
compensate for insufficient anti-flagellin IgA production by increasing the production of IgA 
with alternate specificities. The association of bacteria with the epithelium of the small intestine 
has been shown to increase host IgA production [7], suggesting that increased IgA levels in 
TLR5-/- mice may be a consequence of epithelium-associated bacteria. Increased exposure of the 
epithelium to bacterial products coupled with a defective adaptive immune response against 
flagellin [20] may explain why the abundance of IgA observed in the colon of TLR5-/- mice is 
insufficient to protect the mucosal barrier from being penetrated by a highly flagellated 
microbiota. 
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Figure 3. Elevated levels of secretory IgA are apparent in the large intestine of TLR5-/- 
mice. Each panel displays a fluorescent micrograph of a separate mouse large intestine section 
with TLR5-/- (LEFT) and WT (RIGHT) shown. The images are positioned with host tissues on 
the left and the lumen on the right. BLUE: Nuclei of host villi cells stained with Hoechst 33342. 
GREEN: IgA tagged with a fluorescent anti-IgA antibody (Alexa fluor 488). Food particles in 
the lumen display autofluorescence and may fluoresce blue due to DNA content. Green cells in 
the subepithelium are likely to be IgA-producing plasma cells. The scale bar applies to all 
images. 
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Though I previously measured an increased flagellin load in the cecal contents and fecal 
pellets of TLR5-/- mice, those quantitative assays did not provide information on the location of 
flagellin in relation to host tissues. To investigate the presence of bacterial flagellin in situ, I 
performed immunohistochemistry with antibodies targeting flagellin in large intestine tissues. In 
agreement with prior findings, the presence of flagellin in the colon of TLR5-/- mice was 
strikingly elevated in comparison to WT (Figure 4). Similar to what was observed in the FISH 
images of bacteria in the colon, flagellin also appears in high abundance in the inner mucus layer 
of TLR5-/- mice and virtually absent in the inner mucus layer of WT mice. Interestingly, the 
fluorescence signifying the presence of flagellin revealed what appear to be distinct bacterial 
cells which breached the mucus layer and associated directly with the epithelium in TLR5-/- 
mouse tissues. This suggests that, not only does the gut microbiome of TLR5-/- mice produce 
more flagellin, but that the bacteria breaching the mucosal barrier are indeed flagellated. While I 
did observe a lesser flagellin signal in the lumen of WT tissue preparations, I did not observe the 
presence of distinct bacterial shapes or the presence of flagellin signal in contact with the 
epithelium. This could suggest that the flagellin levels in WT mice are due to low-level 
expression from a diverse suite of bacteria, rather than the presence of highly flagellated bacteria 
that are simply in lower abundance relative to the TLR5-/- microbiome.  
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Figure 4. Bacteria display increased flagellin and penetrance in the large intestine of  
TLR5-/- mice. Each panel displays a fluorescent micrograph of a separate large intestine section 
with TLR5-/- (LEFT) and WT (RIGHT) shown. The images are positioned with host tissues on 
the left and the lumen on the right. BLUE: Nuclei of host villi cells stained with Hoechst 33342. 
GREEN: flagellin tagged with a fluorescent anti-flagellin antibody (Alexa fluor 488). Food 
particles in the lumen display autofluorescence and may fluoresce blue due to DNA content. Red 
arrows indicate bacteria in association with the epithelium and red brackets annotate the 
bacterially sparse inner mucus layer of WT mice. 
  
 95 
 
Multiple studies indicate that intestinal pathogens cannot effectively penetrate the mucus 
layer and invade the epithelium without flagellar motility [30, 31]. Though the same data are not 
available for gut commensal bacteria, my observations suggest that a taxonomically widespread 
increase in flagellation in the gut microbiota of TLR5-/- mice is responsible for the bacterial 
colonization of the colonic inner mucus layer and penetration into the villi of the small intestine. 
My findings indicate that anti-flagellin antibodies quench bacterial motility and that these 
antibodies are significantly reduced in the intestines of TLR5-/- mice. Unfortunately, 
commercially available anti-flagellin antibodies and purified flagellin are greatly limited to the γ-
Proteobacteria species E. coli and S. enterica. This raises questions about the applicability of 
these reagents and the data they help to generate concerning the whole gut microbiome. Though 
γ-Proteobacteria are likely to be important to the development of metabolic syndrome and 
inflammation in TLR5-/- mice, my metatranscriptomics data suggest that most of the flagellin 
present in the gut is produced by bacteria of the Firmicutes phylum. To extend the relevance of 
my findings to Firmicutes, I used a combination of genomic analyses, motility assays, and 
antibody cross-reactivity assays.  
There are seven amino acid residues of the flagellin protein, spread across the amino acid 
positions 88-114 in most γ-Proteobacteria flagellins, that are critical for recognition by TLR5 
[18]. To see if these residues are present in commensal Firmicutes, I aligned annotated flagellin 
peptide sequences with several well-characterized Proteobacteria (Table 1). The presence of 
critical amino acid residues appears to segregate by bacterial class: γ-Proteobacteria and 
Clostridia consistently have all of the critical residues, while α-Proteobacteria, ε-Proteobacteria, 
and Bacilli tend to have only a portion of the critical residues. These data suggest that Clostridia, 
which is the most abundant class of flagellated bacteria found in WT and TLR5-/- mice 
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according to my 16S rRNA sequence analysis, produce flagellin that is capable of eliciting a 
TLR5 response. Interestingly, γ-Proteobacteria and Clostridia share more amino acid sequence 
homology in this region of the flagellin protein that either one shares with more closely-related 
members of their own phylum.  
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 Table 1. Alignment of flagellin peptide sequences showing the amino acid residues critical 
for TLR5 recognition. Amino acid sequences from a variety of flagellin proteins were obtained 
from NCBI and aligned. Amino acid positions known to be critical for eliciting a TLR5 response 
have an asterisk at the top of the alignment and flagellin proteins with the correct residues at 
these positions are underlined red. The species are grouped by class. Note that sequences derived 
from Firmicute species (classes Bacilli and Clostridia) have most, if not all, of the necessary 
residues for TLR5 stimulation . 
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To test if the presence of these critical amino acids was, in fact, sufficient for TLR5 
recognition, I purified flagellin from a variety of cultured bacteria and tested their ability to 
stimulate TLR5 using a HEK cell reporter assay (see Table 2 for strain information). As expected 
based on previous studies and the presence of amino acid residues in the flagellin protein known 
to be important in TLR5 stimulation [18, 32], purified flagellin from all three tested species of γ-
Proteobacteria elicited a TLR5 response (Figure 5, Table 3). I also tested six Clostridia species 
and three Bacilli species and found that flagellin from all of the Clostridia, but none of the 
Bacilli, stimulated TLR5. I included pure LPS from E. coli as well as a mock flagellin extraction 
of the aflagellate Bacillus, Staphylococcus epidermidis, to confirm that neither of these 
substances are capable of eliciting a TLR5 response in the HEK cell reporter assay. These data 
suggest that, while not all flagellated members of the gut microbiome cause TLR5 stimulation, 
many commensal bacteria belonging to a diversity of phylogenies produce flagellin with TLR5 
stimulatory capacity. 
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Table 2. Strain information for bacteria used in this study. 
Genus Species Strain 
Type 
strain Motile Source 
Clostridium ramosum DSM 1402 Y Y DSMZ 
Clostridium scindens ATCC 35704 Y Y DSMZ 
Clostridium bartlettii DSM 16795 Y Y DSMZ 
Roseburia intestinalis L1-82 Y Y DSMZ 
Clostridium bolteae ATCC BAA-613 Y Y DSMZ 
Providencia stuartii ATCC 25827 N Y DSMZ 
Roseburia inulinivorans A2-194 Y Y DSMZ 
Lactobacillus brevis DSM 20054 Y Y DSMZ 
Lactobacillus sakei NRRL B-1917 N Y ATCC 
Citrobacter amalonaticus NRRL B-41228 Y Y ATCC 
Staphylococcus epidermidis ATCC 14990 Y N ATCC 
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Table 3. Ability of flagellin from different bacteria species to stimulate TLR5 in an in vitro 
reporter cell assay. All species are commensal except for Citrobacter amalonaticus and 
Salmonella enterica serovar Typhimurium.  
Species Phylum Class Reactivity 
Citrobacter amalonaticus Proteobacteria γ-Proteobacteria + 
Salmonella Typhimurium Proteobacteria γ-Proteobacteria + 
Providencia stuartii Proteobacteria γ-Proteobacteria + 
Roseburia inulinovorans Firmicutes Clostridia + 
Roseburia intestinalis Firmicutes Clostridia + 
Clostridium scindens Firmicutes Clostridia + 
Clostridium ramosum Firmicutes Clostridia + 
Clostridium bolteae Firmicutes Clostridia + 
Clostridium bartletii Firmicutes Clostridia + 
Staphylococcus epidermidis Firmicutes Bacilli - 
Lactobacillus brevis Firmicutes Bacilli - 
Lactobacillus sakei Firmicutes Bacilli - 
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Figure 5. Flagella harvested from several species of gut commensal Firmicutes and 
Proteobacteria show a strong stimulatory potential for TLR5. We purified flagella from 
three Proteobacteria and nine Firmicutes and assayed for their ability to stimulate TLR5. Purified 
flagellin from S. Typhimurium serves as a positive control and S. epidermidis serves as a 
negative control because it does not produce flagella. Blue diamonds represent boiled flagella 
preparations and red squares represent unboiled preparations. The x-axis represents ng/mL of 
crude flagella extract, displayed on a log10 scale. The y-axis represents alkaline phosphatase 
activity at 620 nm. 
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Next, I wanted to test the ability of anti-flagellin antibodies to cross-react with flagellin 
of bacteria other than the intended target species. To do this, I collaborated with Benoit 
Chassaing and Andrew Gewirtz of Georgia State University to perform Western blots. Benoit 
Chassaing used two different anti-flagellin antibodies either targeting S. enterica serovar 
Typhimurium (anti-FliC) or Roseburia hominis (anti-Fla2) to probe flagellin extracts from a 
variety of species via Western blotting. The anti-R. hominis antibody, which was a component of 
polyclonal antiserum, recognized five of the six Clostridia, two of the three  γ-Proteobacteria—
including S. Typhimurium—and zero of the three Bacilli (Figure 6A). Interestingly, all flagellin 
types that were recognized by the anti-Fla2 antibody also elicited a TLR5 response. One 
Firmicute (C. bolteae) and one γ-Proteobacteria (C. amalonaticus) were not bound by anti-Fla2 
antibody even though they elicited a TLR5 response, suggesting that there is not a perfect 
correlation between the cross reactivity of anti-flagellin antibodies and the immunogenicity of 
flagellin. A few of the bands on the Western are of differing size, but this may be explained by 
the differences in amino acid length of flagellin proteins from various species. For example, the 
flagellin protein of P. stuartii has an amino acid length of 362 while R. intestinalis and R. 
inulinovorans flagellins have lengths of 421 and 426 amino acids, respectively (Table 5) 
according to the online protein databases Uniprot and Patric [33, 34]. The anti-S. Typhimurium 
antibody, which was monoclonal, recognized S. Typhimurium flagellin, but none of the other 
flagellin extracts used (Figure 6B). 
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Figure 6. Immunogenic epitopes are shared between flagella from members of 
Proteobacteria and Firmicute phyla. Western blot analyses of crude flagellin preparations 
from Proteobacteria (1,7,8) and Firmicutes (2-6,9-11) probed with (A) primary polyclonal serum 
antibodies raised against a recombinant flagellin peptide from Firmicute Roseburia hominis, or  
(B) primary monoclonal antibody raised against S. Typhimurium flagellin. Protein size listed in 
kilodaltons to the left of each image. 
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Table 4. Molecule mass of predicted flagellin filaments from the bacteria that were used in  
Western blots. Bacteria are listed with their corresponding flagellin protein as annotated by 
either the Uniprot or Patric online databases. Amino acid length (AA) as well as approximate 
size (kD) are given. Note that not all bacteria used in Western blots had annotated flagellin 
proteins. 
 
Species Uniprot  Patric  
 AA kD AA kD 
P. stuartii 362 39.82 362 39.82 
R. inulinovornas 392 43.12 426 46.86 
R. intestinalis 
Fla1 445 48.95   
R. intestinalis 
Fla2 421 46.31   
S. Typhimurium 495 54.45 495 54.45 
C. amalonaticus 553 60.83   
C. bolteae   501 55.11 
 
  
 107 
 
 If a healthy mouse with an intact immune system uses anti-flagellin IgA to quench the 
motility of its resident microbiota, then one would expect that antibodies derived from this 
mouse would bind to flagellin proteins from a variety of commensal bacteria. To test this, we 
performed Western blots in which the same panel of purified flagellins was probed with a cell-
free fecal supernatant from a healthy WT mouse (Figure 7). The results are not definitive, likely 
because neither the flagellin purifications nor the fecal supernatant are completely pure products, 
but there are striking similarities between the Western blot probed with anti-Fla2 antibody and 
the blot probed with fecal supernatant. For example, both exhibit bands at approximately 60 kD 
in the lanes corresponding to R. inulinovorans, R. intestinalis, C. ramosum, and C. bartletii. 
Confirming this result will likely require the development of protocols to further purify the 
flagellin and purify the fecal antibodies. However, the similarities suggest that healthy mice 
produce secretory antibodies that recognize and bind flagellin from a diversity of Firmicutes in 
much the same way that the antibody produced against R. hominis flagellin (Fla2) is cross-
reactive in nature. 
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Figure 7. IgA from WT mice recognizes flagellin from multiple commensal bacteria. 
Western blot analyses of crude flagellin preparations from Proteobacteria (1,7,8) and Firmicutes 
(2-6,9-12) probed with antibody-containing fecal supernatant from a WT mouse. Protein size 
listed in kilodaltons to the left of each image. 
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 To better understand if anti-flagellin antibodies inhibit motility in flagellated Firmicutes 
in the same way that occurs in γ-Proteobacteria, I performed time-lapse microscopy of cultured 
bacteria after the addition of anti-flagellin antibodies. I used two flagellated Firmicutes common 
to the gut microbiota—Roseburia intestinalis and Clostridium ramosum—and observed that both 
displayed inhibited motility within 30 minutes after introducing anti-FliC antibody or anti-Fla2 
antibody. This is in contrast to the control cultures that were mixed with water or anti-mouse 
antibody, which did not show decreased motility after 30 minutes. Videos are available for 
download and viewing on Cornell University Library eCommons website 
(http://ecommons.library.cornell.edu/handle/1813/31547), which is a digital repository. These 
data indicate that, similar to E. coli and S. Typhimurium, flagellated Firmicutes also experience 
inhibited motility when exposed to anti-flagellin antibodies. 
As further confirmation that the microbiome of TLR5-/- mice exhibits an increased 
frequency of motile bacteria compared to the WT microbiome, I performed similar time lapse 
microscopy using freshly dissected large intestines from each mouse type. Not only do bacteria 
harvested from the large intestine of TLR5-/- mice appear to display increased motility compared 
to bacteria from WT mice, but bacteria from both mouse types displayed decreased motility 
within one hour after the addition of anti-FliC or anti-Fla2 antibody compared to a no-antibody 
control. Videos are available for download and viewing on Cornell University Library 
eCommons website (http://ecommons.library.cornell.edu/handle/1813/31548). These results 
agree with the finding that more flagella-related transcripts exist in the transcriptome of the 
bacterial community in TLR5-/- mice. Further, the videos support the idea that anti-flagellin 
antibodies secreted into the gut can act to inhibit motility in a wide range of bacterial taxa by 
cross reacting with multiple flagellin types. 
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4.4 Conclusion 
 Together, these results expand our understanding of the phenotype presented by TLR5-/- 
mice by revealing a disrupted mucosal barrier in the intestine and suggesting that commensal 
Firmicutes can function in much the same way as γ-Proteobacteria in their TLR5 stimulatory 
capacity and response to anti-flagellin antibodies. Simply due to a lack of TLR5, these mice fail 
to maintain functional mucus layers and adequate IgA repertoires. Previous studies indicate that 
gut IgA can protect the epithelium from commensal bacteria through steric hindrance, binding 
adhesion epitopes, anchoring bacteria to mucus via IgA secretory component, and agglutination 
[35, 36]. My results expand this view by suggesting that anti-flagellin IgA is also important in 
limiting flagellation of commensal bacteria, thus protecting against penetration into host tissues. 
Since the outer mucus layer is an important site of nutrients and colonization by commensal 
bacteria, the disrupted stratification of mucus observed in TLR5-/- mice may serve to exacerbate 
the host damage caused by commensal bacteria as they attempt to occupy alternative niches. The 
similarities in symptoms presented by individuals with inflammatory bowel disease [37], primary 
antibody disorders [38], and TLR5-/- mice suggest that the loss of gut homeostasis may have 
fairly universal causes at its core. 
 
 
4.5 Materials and methods 
Tissue preparation for microscopy: All procedures performed were reviewed and approved by 
the Cornell University IACUC in advance.  Mice were euthanized individually and dissected by 
Mary E. Bell using CO2 inhalation and large and small intestine were and immediately placed 
into Carnoy solution (60% absolute ethanol, 30% chloroform, 10% glacial acetic acid) without 
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luminal washing. All procedures were completed by approximately 12 minutes post-mortem. For 
motility assays, the large intestines were processed similarly, but instead of placing in Carnoy 
solution, they were immediately placed into an anaerobic chamber in order to best maintain the 
active motility of strict anaerobic bacteria. Carnoy-fixed tissues were allowed to fix for 24 hours 
before being transferred to 70% ethanol and submitted for processing at the Animal Health 
Diagnostic Center Histology Laboratory, Cornell University. There, the tissues were embedded 
in paraffin, sectioned at a width of 5 microns, and mounted on glass slides. To deparaffinize and 
rehydrate the tissues, I passaged the slides 3 times in 100% xylene, then 80% ethanol, then 50% 
ethanol, each for 20 min. I encircled the tissues on each slide with a Super PAP Pen (Daido 
Sangyo Co., Ltd. Tokyo, Japan) to increase liquid retention. I used this procedure for both FISH 
and immunohistochemistry assays.  
 
Fluorescent in situ hybridization: I selected rRNA probes using probeBase [39]. I chose 
EUB338 (5’- GCT GCC TCC CGT AGG AGT -3’) [40] as a universal 16S rRNA probe and 
GAM42a (5’- GCC TTC CCA CAT CGT TT -3’) as a γ-Proteobacteria 23S rRNA probe [41]. 
There is not a single comprehensive probe for the phylum Firmicutes, so to more thoroughly 
detect the Firmicutes I used three 16S rRNA probes in an equimolar ratio: LGC354a (5’ - TGG 
AAG ATT CCC TAC TGC - 3’), LGC354b (5’ - CGG ATT CCC TAC TGC - 3’), and 
LGC354c (5’- CCG AAG ATT CCC TAC TGC - 3’) [42]. As a specificity control, I chose 
NONEUB (5’- ACT CCT ACG GGA GGC AGC -3’) which has been shown to not recognize 
bacterial ribosomal sequences [43]. The universal bacteria and γ-Proteobacteria probes were 
conjugated to Alexa Fluor 488 (Invitrogen, Carlsbad, California) and the Firmicutes and 
specificity probes were conjugated to Alexa Fluor 555. I mixed the specificity probe in 
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equimolar ratios with each of the target probes. To make the bacterial cells more amenable to 
FISH probing, I partially digested them by incubating the slides at 37°C for 1 hour with 150 µl 
proteinase buffer (0.05M EDTA, 0.1M Tris-HCl, 1.5% lysozyme from chicken egg white 
(Sigma-Aldrich, St. Louis, Missouri)). I then rinsed slides in sterile water and added 135 µl of 
hybridization buffer (30% formamide, 0.0002% SDS, 0.02M Tris-HCl, 0.9M NaCl) that I 
premixed with 15 µl of 50 ng/µl Alexa Fluor conjugated probe (Invitrogen, Carlsbad, 
California). Probes were allowed to hybridize overnight at 46°C in a humidified chamber 
without light. I constructed humidified chambers by wrapping 50 ml conical vials in aluminum 
foil and placing a strip of wetted filter paper inside, such that the vials each held a single slide 
and were laid sideways within a precision incubator. I then rinsed slides in 48°C washing buffer 
(0.02M Tris-HCl, 0.112M NaCl, 0.005M EDTA, 0.0001% SDS) and incubated slides in fresh 
washing buffer for 30 minutes at 48°C. After that, I rinsed slides in ice cold water and allowed 
them to dry without exposing to light. To stain host tissue, I incubated slides with 150 µl of 2 
µg/ml Hoechst 33342 (Invitrogen, Carlsbad, California) for 5 minutes before rinsing with sterile 
water and allowing to dry once more. I mounted finished slides with the Prolong Antifade Kit 
(Invitrogen, Carlsbad, California) according to manufacturer’s instructions.  
 
Immunohistochemistry: I washed slides twice for 5 minutes in Tris-buffered saline (TBS) 
(50mM Tris-Cl, 150mM NaCl, pH 7.5) plus 0.025% Triton X-100 with gentle agitation. I then 
blocked the tissues for 2 hours at room temperature with 150 µl of 10% normal goat serum 
(Sigma-Aldrich, St. Louis, Missouri) with 1% BSA in TBS, after which I drained off the 
blocking solution and applied either rabbit anti-flagellin IgG (Abcam, Cambridge, 
Massachusetts) or FITC-conjugated goat anti-mouse-IgA (Sigma-Aldrich, St. Louis, Missouri) 
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diluted 1:100 in TBS with 1% BSA and incubated the slides overnight at 4°C. The following 
morning I rinsed the slides twice for 5 minutes in TBS plus 0.025% Triton X-100. I incubated 
the anti-flagellin slides for 1 hour at room temperature with 150 µl of TBS with 1% BSA and 
0.1% CHROMEOsity 488-conjugated goat anti-rabbit IgG (Neuromics Antibodies, Edina, 
Minnesota). I then rinsed the slides 3 times for 5 minutes each in TBS, allowed them to dry, and 
incubated slides with 150 µl of 2 µg/ml Hoechst 33342 (Invitrogen, Carlsbad, California) for 5 
minutes before rinsing with sterile water and allowing to dry once more. Finally, I mounted the 
slides using the Prolong Antifade Kit (Invitrogen, Carlsbad, California) according to 
manufacturer’s instructions.  
 
Fluorescent microscopy: All fluorescent microscopy was performed on a Zeiss LSM 710 
confocal microscope equipped with Zen system software via the Microscopy and Imaging 
Facility at Cornell University. Unless stated otherwise, I used a 63x oil immersion objective and 
405 and 488 nm emitting lasers. I adjusted laser power to 2% and held master gain between 500-
750, with a digital offset of 0. To maintain high resolution, I used unidirectional scanning and a 
maximum pixel size of 1024 × 1024. 
 
Bacterial cultures: I cultured Lactobacillus brevis and Lactobacillus sakei in MRS liquid 
medium and all Proteobacteria in LB liquid medium in an aerobic environment with shaking at 
37°C overnight. I cultured all other Firmicutes in M2GSC liquid medium in 100 ml anaerobic 
serum vials which were incubated at 37°C for 24 hours or longer depending on observed growth 
rate. 
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Flagellin purification: I transferred 80 mL of each culture into two 50 mL conical vials, divided 
evenly, and sheared flagellin from the bacteria with two minutes of vortex agitation. I then 
centrifuged the cultures at 2,754x (g) for 30 minutes at 4° C in order to pellet bacterial cells and 
debris. I transferred the resulting supernatants into 30 mL ultracentrifuge tubes and centrifuged 
the samples at 40,000 rev/minute for 1.5 hours at 4° C. I resuspended the resulting pellets in 1 ml 
of PBS and centrifuged the samples once more at 5,000 rev/minute for 30 minutes at 4° C in 
order to pellet any remaining large cellular debris. In order to reduce the confounding factor of 
endotoxin present in the flagellar purification of Gram-negative bacteria, I then detoxified the 
samples with polymyxin B using Detoxi-Gel AffinityPak Pre-packed Columns (Thermo 
Scientific, Rockford, Illinois).  
 
Motility assays using time lapse microscopy: I cultured Roseburia intestinalis and Clostridia 
ramosum under strict anaerobic conditions before applying 10 µl of culture with either 1 µl of 
anti-flagellin antibody or water to a glass slide. I processed mouse colonic contents by opening 
the colon at its approximate midpoint with a razor, removing approximately 50 mg of colonic 
contents via scraping, and diluting the contents with 2 ml of PBS buffer, all under anerobic 
conditions. I prepared the diluted colonic contents in the same manner as the bacterial cultures. I 
sealed the cultures or colonic contents with a glass cover slip and acrylic sealant and allowed the 
sealant to dry fully before removing from the anaerobic chamber. I immediately captured a short 
time lapse video with bright field microscopy in order to achieve a sense for baseline motility. I 
captured a second time lapse video after 30 minutes (bacterial cultures) or 60 minutes (colonic 
contents) in order to observe potential changes in the frequency or degree of bacterial motility. 
All time lapse microscopy was performed on an upright Olympus BX-50 microscope with a 60x 
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magnification objective and the Metamorph imaging system. I made the videos with a spacing of 
0.3 seconds over the course of 35 frames. 
 
Statistics: I performed statistical analysis in Microsoft Excel 2011. Statistical test was unpaired 
student ‘t’-test, as indicated. Significance level of p<0.05 unless otherwise indicated. All 
multiple comparison testing was accounted for with Bonferroni correction. 
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5. Conclusion 
  
My research presented here has been devoted to understanding how TLR5 directs the 
production of anti-flagellin IgA in order to quench bacterial motility in the gut and thus protect 
against gut inflammation. In the absence of TLR5, the host produces insufficient levels of anti-
flagellin IgA and the microbiota responds by increasing flagellation. Using metatranscriptomics 
and metagenomics of the gut bacterial community, I found that this increase in flagellation is due 
to a shift in protein expression rather than a shift in phylogenetic composition and that a diverse 
suite of commensal bacteria are responsible for the increased flagellin observed in TLR5-/- mice. 
The defective anti-flagellin adaptive immune response in TLR5-/- mice is more strongly tied to 
their innate immune defect rather than their increased gut inflammation. I came to this 
conclusion because MyD88-/- mice, which have impaired TLR5 signaling, display flagellin and 
anti-flagellin concentrations similar to TLR5-/- mice whereas WT mice treated with DSS, which 
induces gut inflammation, display parameters more similar to non-inflamed WT mice.  
I also observed this inverse relationship between flagellin and anti-flagellin antibodies in 
human fecal samples. Interestingly, flagellin load was positively correlated with BMI in these 
individuals, suggesting that obesity and a deficiency in anti-flagellin IgA may somehow be 
linked. As TLR5-/- mice also display obesity, these findings promote the intriguing idea that 
obesity coupled with defective control of the flagellated gut microbiota could be a universal 
phenomenon among mice and humans. Future work may elaborate on these results by 
incorporating a larger human sample size and seeking out individuals with TLR5 deficiencies. 
Initial studies suggest that human TLR5 deficiency protects from obesity and Crohn’s disease 
but predisposes to type II diabetes [1, 2], but the mechanisms behind these correlations remain 
unknown. 
 121 
 
I found that the addition of anti-flagellin antibodies to in vitro bacterial cultures induced 
downregulation of flagellin and a severe decrease in motility, suggesting that the inverse 
relationship between anti-flagellin IgA levels and flagellin load in the gut is causal rather than 
just correlative. Despite the high metabolic expenditure required for flagellation, I was not able 
to observe a fitness advantage due to the presence of flagella, as flagellated bacteria were not 
better suited to colonizing the gut than aflagellate bacteria of the same strain. This may have 
been due to the relatively simple communities that I used to investigate this issue and future 
work involving more complex communities may be required to understand the benefits of 
flagellation for nonpathogenic gut bacteria. 
The results in chapter two highlight the importance of IgA in maintaining temporal 
evenness and stability of the gut microbiota and suggest that a particular suite of IgA specificities 
is required in order to coat the proper bacteria. In the absence of antibodies, the gut microbiota 
was not phylogenetically distinct, but rather displayed more volatility and an increased 
susceptibility to change when confronted with environmental perturbation. Likewise, the 
bacterial community of TLR5-/- mice was not distinct from the WT microbiota despite the 
observation that these host types display significantly different profiles of the bacterial types 
coated with IgA. Specifically, TLR5-/- mice display increased IgA coating of Firmicutes and 
decreased IgA coating of Proteobacteria compared to WT mice. These findings have important 
implications for human health because a hallmark of gut homeostasis is the ability to maintain a 
stable community of symbiotic bacteria [3, 4] and IgA appears to be an important mechanism of 
achieving this stability. Despite IgA deficiency being the most common primary 
immunodeficiency, clinical measurements are not currently a part of routine screenings and are 
almost always performed on blood serum rather than at mucosal sites [5]. This, coupled with the 
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fact that circulatory IgA and secretory IgA are produced through fairly distinct mechanisms [5], 
suggests that many mucosal antibody deficiencies are likely to go undiagnosed.  
In chapter three I provide evidence that TLR5-/- mice indeed have a defective mucosal 
barrier that results in flagellated bacteria penetrating further into the mucus. This results in 
epithelia-adherent bacteria in the colon and invasion of villi tissues in the small intestine. I found 
that flagellin proteins from a variety of commensal bacteria are capable of stimulating TLR5 
which, coupled with my observation that flagellin transcripts in the TLR5-/- mouse belong to a 
diverse suite of bacteria, suggests that the pathogenesis of TLR5 deficiency is due to a broad 
shift in genetic expression of the gut microbiota. This corroborates an inability to detect a 
specific pathogen responsible for the phenotype of TLR5-/- mice.  
It has yet to be proven if TLR5-deficient individuals can be protected against 
inflammation by the therapeutic introduction of anti-flagellin antibodies. Another potential 
therapeutic strategy is the development of a vaccine that can bypass the requirement of TLR5 
and induce the production of high amounts of anti-flagellin antibodies via alternative routes. One 
potential avenue for the creation of such a vaccine is the combination of short flagellin peptides 
with a proper adjuvant. Flagellin peptides processed to correspond to a highly conserved, 
immunogenic region of the protein have shown to elicit the maturation of flagellin-specific T 
cells when full-length flagellin failed to do so in TLR5-/- mice [6], suggesting that these peptides 
do not require TLR5 to initiate an adaptive immune response. Such a vaccine might be 
successfully introduced into the gut via encapsulation and ingestion or a probiotic bacterium 
could even be engineered to secrete the peptide directly into the luminal environment [7]. If the 
positive correlation between flagellin load and BMI is a common trait in humans, as suggested 
by my findings, then the development of such a vaccine could have profound implications for 
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treating the increased inflammation exhibited by the growing percentage of the population living 
with obesity. 
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